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Abstract 
Drusen are discussed frequently in the context of their association with age-related macular 
degeneration (AMD). Some types may, however, be regarded as a normal consequence of 
ageing; others may be observed in young age groups. They also occur in a number of 
inherited disorders and some systemic conditions. Whilst drusen are classically located 
external (sclerad) to the retinal pigment epithelium, accumulations of material internal 
(vitread to) this layer can display a drusen-like appearance, having been variously termed 
pseudodrusen or subretinal drusenoid deposits. This review first briefly presents an 
overview of drusen biogenesis and subclinical deposit. The (frequently overlapping) 
subtypes of clinically detectable deposit, seen usually in the context of ageing or AMD, are 
then described in more detail, together with appearance on imaging modalities: these 
include hard and soft drusen, cuticular drusen, reticular pseudodrusen and “ghost drusen”. 
Eye disorders other than AMD which may exhibit drusen or drusen-like features are 
subsequently discussed: these include monogenic conditions as well as conditions with 
undefined inheritance, the latter including some types of early onset drusen such as large 
colloid drusen. A number of systemic conditions in which drusen-like deposits may be seen 
are also considered. Throughout this review, high resolution images are presented for most 
of the conditions discussed, particularly the rarer ones, providing a useful reference library 
for images of the range of conditions associated with drusen-like appearances. In the final 
section, some common themes are highlighted, as well as a brief discussion of some future 
avenues for research.  
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List of abbreviations 
AF  Autofluorescence 
AMD  Age-related macular degeneration 
AO  Adaptive optics 
BlamD  Basal laminar deposit 
BlinD  Basal linear deposit 
BM  Bruch’s Membrane 
CD  Cuticular drusen 
CSLO  Confocal scanning laser ophthalmoscope 
ECM  Extracellular matrix 
FFA  Fundus fluorescein angiography 
FAF  Fundus autofluorescence 
ICGA  Indocyanine green angiography 
IRR  Infrared reflectance 
L-ORD  Late-onset retinal degeneration 
MMP  Matrix metalloproteinase 
MPGN  Membranoproliferative glomerulonephritis 
NCMD  North Carolina Macular Dystrophy 
NIRR  Near infrared reflectance 
OCT  Optical coherence tomography 
PAS  Periodic acid Schiff 
PED  Pigment epithelial detachment 
PPi  Pyrophosphate 
PXE   Pseudoxanthoma elasticum 
RPD  Reticular pseudodrusen 
RPE  Retinal pigment epithelium 
SDD  Subretinal drusenoid deposit 
SFD  Sorsby fundus dystrophy 
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SLS  Sjogren-Larsson syndrome 
SWAF  Short wavelength autofluorescence 
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1. Introduction 
Drusen (singular: druse) are accumulations of extracellular material immediately beneath 
(i.e. external, or sclerad, to) the retinal pigment epithelium (RPE). They have been discussed 
for over 150 years, having been first described by Franciscus Donders who called them 
"Colloidkugeln" (colloid spheres) (Donders, 1855). He considered them gravestones of the 
RPE. A year later Heinrich Müller coined the name drusen, after their glistening appearance, 
from the German word for geode, a rock containing a crystal lined cavity (Muller, 1856). 
Drusen may be a manifestation of the normal ageing process or represent an important sign 
associated with retinal disease (Ardeljan and Chan, 2013). Differentiating the two depends 
upon a careful assessment of the drusen characteristics, although there is a degree of 
overlap. The biochemical processes associated with ageing, accelerated or modified by 
genetic and environmental factors, can result in drusen and in progression to disease. 
Significant advances have been made in our understanding of drusen over the last 10 years 
especially with the advent of high-resolution in vivo retinal imaging.  
There are a number of different systems for classifying drusen or drusenoid lesions. These 
include categorization based on size, location, shape, appearance with multi-modal imaging, 
microscopic appearance, and molecular composition. The classification systems overlap, but 
do not map discretely onto one another. Matters are further complicated by the fact that 
definitions and terms of reference may change: the same name has been used for different 
phenotypic entities over time. “Location” can refer to whether the lesion is found in the 
macular region or peripheral retina, and may also refer to the proximal-to-distal layer or 
sublayer in which the lesion is found (internal to or external to the retinal pigment 
epithelium (RPE) for example). The former will be referred to as the “x-y location”, and the 
latter the “z-axis” in this review. 
 
1.1 Structure and scope of the review 
In this review we aim to characterise drusen and drusen-like (drusenoid) deposits 
systematically, highlighting key differentiating features where present. To do this end we 
will rely primarily on clinically available forms of imaging, but correlate findings with 
histological data where possible. A key feature of this review is that, in addition to discussing 
drusen in the traditional context of ageing or age-related macular degeneration (AMD), we 
will also consider in some detail a range of inherited and/or systemic disorders in which 
lesions with a drusen-like appearance may occur. 
In the first part of the review, we aim to discuss the various phenotypes associated with 
drusen and drusenoid lesions, starting with a brief review of subclinical features, followed by 
a comprehensive review of the clinical subtypes, primarily evidenced from studies of age-
related macular degeneration (AMD). In the next section, we will go on to discuss the 
occurrence of drusen and drusen-like lesions in retinal pathological processes other than 
AMD: these include lesions associated with abnormalities of the visual cycle, other eye-
specific disorders, and disorders with systemic manifestations, including renal disease. Many 
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of the diseases mentioned are monogenic, or have strong genetic associations. Table 1 lists 
the genes mentioned in the text with OMIM (Online Mendelian Inheritance in Man, an 
online catalogue of genes and disorders) numbers for reference.  
Optic disc drusen (collections of material within retinal ganglion cell axons due to impaired 
flow) will not be discussed. Crystalline retinopathies (reviewed by Nadim et al., 2002) will 
not be considered, though in some cases they may resemble calcified drusen. Drusen 
occurring in the context of localised well-defined choroidal lesions, such as over a choroidal 
naevus, where they can indicate chronicity, will not be discussed. Also, the inflammatory 
“white dot syndromes” are beyond the scope of this review.  
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Table 1. Genes mentioned in this review. (Abbreviations not explained in table: EGF, 
epidermal growth factor; DFFA, DNA fragmentation factor alpha subunit.)  
Name Meaning of 
abbreviation 
OMIM 
number 
Cytogenetic 
location 
Associated diseases Drusen/drusenoid 
appearance phenotype 
ABCA4 ATP-binding cassette, 
subfamily A, member 
4 
601691 1p22.1 Stargardt disease; macular 
dystrophy; cone-rod 
dystrophy 
White dots in the central 
macula (Platano et al.); 
outer retinal flecks and 
deposits  
ABCC6 ATP-binding cassette, 
subfamily C, member 
6 
603234 16p13.11 Pseudoxanthoma elasticum Subretinal drusenoid 
deposits, white dots 
(Platano et al.)  
ARMS2 Age-related 
maculopathy 
susceptibility 2 
611313 10q26.13 Suseceptibility to AMD Drusen associated with 
AMD 
C2; C3; 
C9 
Complement 
components 2, 3, 9 
613927; 
120700; 
120940 
6p21.33; 
19p13.3; 
5p13.1 
Complement component 
deficiencies (C2, C3, C9), 
susceptibility to atypical 
haemolytic uraemic 
syndrome (C3), risk of AMD  
Drusen associated with 
AMD 
CDHR1 Cadherin-related 
family, Member 1 
609502 10q23.1 Range of retinal phenotypes; 
cone-rod dystrophy 
Hard drusen 
CFB Complement Factor B 138470 6p21.33 Complement factor B 
deficiency, susceptibility to 
atypical haemolytic uraemic 
syndrome, risk of AMD 
Drusen associated with 
AMD 
CFH Complement Factor H 134370 1q31.3 Complement factor H 
deficiency, 
membranoproliferative 
glomerulonephritis type 2, 
atypical haemolytic uraemic 
syndrome, risk of AMD 
Widespread soft drusen, 
cuticular drusen, AMD 
CFI Complement Factor I 217030 6p21.33 Complement factor I 
deficiency, susceptibility to 
atypical haemolytic uraemic 
syndrome, risk of AMD 
Drusen associated with 
AMD 
CIDEC Cell-death inducing 
DFFA-like effector C 
612120 3p25.3 Familial partial lipodystrophy 
type 5 
Hard drusen, cuticular 
drusen 
COL4A3 Collagen, Type IV, 
Alpha-3 
120070 2q36.3 Autosomal recessive Alport 
syndrome; autosomal 
dominant Alport syndrome; 
benign familial haematuria 
Retinal flecks (hyper-
reflective inner limiting 
membrane); possibly 
mid-peripheral drusen 
 COL4A4 Collagen, Type IV, 
Alpha-4 
120131 2q36.3 Autosomal recessive Alport 
syndrome; benign familial 
haematuria 
COL4A5 Collagen, Type IV, 
Alpha-5 
303630 Xq22.3 X-linked Alport syndrome 
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C1QTNF
5 
Complement 
component 1, q 
subcomponent and 
tumor necrosis factor-
related protein 5 
608752 11q23.3 Late-onset retinal 
degeneration 
SDD, hard drusen, soft 
drusen, ‘ghost’ drusen 
EFEMP1 EGF-containing fibulin-
like extracellular 
matrix protein 1 
601548 2p16.1 Doyne honeycomb 
dystrophy; dominant drusen; 
Mallatia Leventinese 
Hard drusen, cuticular 
drusen that coalesce 
FALDH Fatty aldehyde 
dehydrogenase 
609523 17p11.2 Sjogren-Larsson syndrome Superficial retinal crystals 
IMPG1 Interphotoreceptor 
matrix proteoglycan 1 
602870 6q14.1 Vitelliform macular 
dystrophy 
Macular hard drusen  
IMPG2 Interphotoreceptor 
matrix proteoglycan 2 
607056 3q12.3 Vitelliform macular 
dystrophy; retinitis 
pigmentosa 
Macular hard drusen 
LRAT Lecithin retinol 
acyltransferase 
604863 4q32.1 Leber congenital amaurosis; 
early onset severe retinal 
dystrophy; retinitis 
pigmentosa 
White dots 
PLA2G5 Phospholipase A2 
Group V 
601192 1p36.13-
p36.12 
Familial benign fleck retina Numerous white dots 
sparing the macula 
PRDM13 Positive Regulatory 
(PR) Domain 
containing 13 
Not listed 6q16.2 North Carolina Macular 
Dystrophy 
Grade 1 shows small 
hard drusen-like lesions 
PRPH2 Peripherin 2 179605 6p21.1 Macular dystrophy 
(vitelliform macular 
dystrophy; pattern 
dystrophy); retinitis 
pigmentosa; Leber 
congenital amaurosis 
Outer retinal dots, flecks 
or deposit 
RBP4 Retinol-binding 
protein 4 
180250 10q23.33 Isolated microphthalmia 
and/or coloboma; retinal 
dystrophy, iris coloboma, 
and comedogenic acne 
syndrome 
RPE migration into retina 
RDH5 Retinol 
dehydrogenase 5 
601617 12q13.2 Fundus albipunctatus Numerous white dots 
sparing the macula 
RDH12 Retinol 
dehydrogenase 12 
608830 14q24.1 Leber congenital amaurosis Heavy RPE migration and 
macular fibrosis 
RLBP1 Retinaldehyde-binding 
protein 1 
180090 15q26.1 Bothnia dystrophy, fundus 
albipunctatus, 
Newfoundland rod-cone 
dystrophy, retinitis 
pigmentosa 
Numerous white dots 
sparing the macula, 
evolve to atrophy 
RPE65 Retinal pigment 
epithelium-specific 
protein 65-kD 
180069 1p31.3-p31.2 Leber congenital amaurosis; 
early onset severe rod-cone 
dystrophy 
White dots 
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SPG11 Spastic paraplegia 
gene 11 
610844 15q21.1 Autosomal recessive spastic 
paraplegia 11; juvenile 
amyotrophic lateral sclerosis 
5 
Outer retinal deposit, 
flecks 
TIMP3 Tissue inhibitor of 
metalloproteinase 3 
188826 22q12.3 Sorsby fundus dystrophy SDD, hard drusen, soft 
drusen 
ZFYVE26 Zinc finger FYVE 
domain-containing 
protein 26 
612012 14q24.1 Autosomal recessive spastic 
paraplegia 15 
Outer retinal deposit, 
flecks 
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1.2 Imaging modalities 
Given the importance of multi-modal imaging in characterising drusen and drusenoid 
deposits, we will provide representative examples of non-invasive retinal imaging 
appearances of most of the diseases discussed, particularly those which are less frequently 
encountered, or less well-described in the literature.  
There is a range of retinal and choroidal imaging technology currently available, some 
incorporating automated segmentation, volume quantification and even drusen analysis 
(Kanagasingam et al., 2014). Relative strengths of commercially available systems from 
different manufacturers will not be discussed. The systems used to generate the images 
featured in this review are as follows. Colour fundus images in most cases were acquired 
with the Topcon colour fundus camera (Topcon TRC 50IA, Topcon Corporation, Tokyo, 
Japan) unless wide-field imaging is specified, in which case images were acquired using the 
Optos wide-field system (Optos plc, Dunfermline, Scotland, UK), which provides a 
pseudocolour image generated from the two monochromatic laser wavelengths used. Short 
wavelength autofluorescence (Appiah et al.), infrared reflectance (IRR) and spectral domain 
optical coherence tomography (Procter et al.) images were acquired using the Spectralis 
multi-modal confocal scanning laser ophthalmoscope imaging system (Heidelberg 
Engineering, Heidelberg, Germany). Some images acquired using the “Multicolor” setting of 
this instrument (combining red, green and blue wavelength reflectance imaging) are shown. 
Also, in a few cases, wide-field autofluorescence images acquired with the Optos system are 
used. Finally, in Figure 21 the OCT scans and colour fundus photograph in the upper panels 
were acquired using the Topcon 3D-OCT 2000 imaging system (Topcon Corporation, Tokyo, 
Japan). 
 
2. Biogenesis of drusen and types of subclinical deposit 
2.1 Overview of drusen biogenesis 
Bruch’s membrane is a lamellar extracellular matrix (ECM), consisting of an elastic layer 
sandwiched between two collagenous membranes, themselves bordered by basement 
membranes from the RPE (internally) and choriocapillaris (externally). Lipoproteins begin to 
accumulate within the elastic layer during early adulthood and slowly fill the interfibrillar 
spaces of both the elastic layer and the inner collagenous layer. The hydraulic conductivity 
of Bruch’s membrane has been shown to drop with age, and this is more pronounced at the 
macula (Moore et al., 1995). Consequent disruption of transport between RPE and choroid is 
likely to be of relevance. The site of greatest resistance has been shown to be the inner 
collagenous layer (Starita et al., 1997). The reduction in transport capability with age 
appears to be, partly at least, dependent on the lipid content (Starita et al., 1996).  
The “lipid wall” has been proposed as a necessary, but not sufficient, step in drusen 
biogenesis (Curcio et al., 2011). Oxidation of the trapped lipoproteins results in the 
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generation of toxic intermediates, with consequent activation of the inflammatory cascade, 
either via direct complement activation or indirectly by inducing tissue injury and triggering 
apoptosis (Beattie, 2009; Dasari et al., 2010; Kaemmerer et al., 2007). Dendritic cells are 
subsequently recruited (Hageman et al., 2001). Depending upon the genetic background, 
this inflammatory response may be abnormally propagated for years, with the addition of 
peripheral substrates to the initial inflammatory core.  
The molecular processes involved in drusen biogenesis are a major focus of research, and 
several studies have implicated altered heavy metal homeostasis. Maculas affected by AMD 
have increased levels of iron (Hahn et al., 2003). Iron accumulation has been specifically 
demonstrated within Bruch’s membrane and in RPE and choroidal melanosomes in eyes 
affected with AMD (Biesemeier et al., 2015). Zinc is likely to play an important role: levels 
are high in in sub-RPE  deposits (Lengyel et al., 2007), and in excess of that required to 
facilitate oligomerisation of complement factor H and C3b (Nan et al., 2013; the role of 
complement in drusen formation is discussed below in section 2.3). It is likely that protein 
self-association may precede or promote subsequent lipid accumulation. 
Thompson and colleagues have recently investigated human BM using fluorescence 
microscopy and X-ray diffraction, identifying small (<20 μm in diameter), hollow 
hydroxyapatite spherules (Thompson et al., 2015). Secondary ion mass spectrometry 
imaging confirmed the presence of calcium phosphate in the spherules and identified 
cholesterol enrichment in their core. They proceeded to show that all types of sub-RPE 
deposits in the retina contain numerous hydroxyapatite spherules, and are coated with 
proteins characteristic of sub-RPE deposits, such as complement factor H, vitronectin, and 
amyloid beta. Hydroxyapatite spherules were also found outside the sub-RPE deposits, 
ready to bind proteins at the RPE/choroid interface. Based on these discoveries, the authors 
propose a novel mechanism for the growth, and possibly formation of sub-RPE deposits; this 
begins with the deposition of hydroxyapatite shells around naturally occurring, cholesterol-
containing extracellular lipid droplets at the RPE/choroid interface, proteins and lipids then 
attach to these shells, resulting in growth of sub-RPE deposits (Thompson et al., 2015). 
In addition, the role of alterations in cholesterol homeostasis in drusen development is 
becoming a subject of increasing research with likely important implications for AMD 
pathogenesis (Pikuleva and Curcio, 2014). 
 2.2 Types of subclinical deposit 
Long before we are able to visualise drusen, major subclinical changes have already taken 
place. Thus clinically apparent drusen may be thought of as “the tip of the iceberg”. The 
following sections briefly summarise subclinical deposits with respect to location (z-axis). 
Figure 1 depicts the development of these changes schematically. 
Figure 1. Development of subclinical deposits and soft drusen. In this cartoon the healthy 
configuration is shown on the left. With ageing (middle diagram), basal laminar deposits 
accumulate (internal to the RPE basement membrane) and vacuoles appear within RPE 
cells; early basal linear deposits (external to the RPE basement membrane) may also 
develop. The right-hand side shows more extensive BlinD coalescing to form soft drusen. 
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(PR OS, photoreceptor outer segment; RPE, retinal pigment epithelium; BL, basal lamina; 
CL, collagenous layer; EL, elastic layer;  CC, choriocapillaris; BlamD, basal laminar deposit; 
BlinD, basal linear deposit). 
 
2.2.1 Subclinical deposit internal to the RPE basement membrane 
Histologically, these early preclinical stages are defined by the presence of widespread 
thickening of BM, originally termed basal linear deposit (BlinD) by Sarks et al. (Loffler and 
Lee, 1986; Sarks, 1973). As the overlying RPE remains intact, this thickening is 
ophthalmoscopically invisible. Histologically, with a trichrome stain, the deposit appears 
similar to collagen, whilst with a periodic acid Schiff (PAS) stain it shares similarity with 
glycoproteins. Using electron microscopy, the material is visible as small deposits on the RPE 
basement membrane (basal lamina), between the basal lamina and the cytoplasmic 
membrane. This deposit, previously referred to as BlinD, was then renamed basal laminar 
deposit (BlamD), due to its accumulation along the basal lamina of the RPE (van der Schaft et 
al., 1991). It consists mainly of fibrous long-spacing collagen (FLSC), structures that are also 
seen on ageing basement membrane in the cornea (Descemet membrane) and iridocorneal 
angle (trabecular basement membrane) (van der Schaft et al., 1991). As this material 
accumulates, the RPE cells are slowly elevated from their basement membrane until 
subclinical (microscopic) detachments develop.  
BlamD does not appear to be specific to or “diagnostic” for AMD and is part of ageing. It may 
be thought of a generic epithelial cell stress response, as the ageing RPE secretes excessive 
amount of basement membrane in an attempt to remain adherent. There is however a 
strong relationship between macular BlamD and the subsequent development of exudative 
AMD and visual loss (Feeney-Burns and Ellersieck, 1985; Loffler and Lee, 1986; Spraul and 
Grossniklaus, 1997). BlamD-like deposition is observed in monogenic macular disorders with 
a clinical appearance similar to AMD namely Sorsby fundus dystrophy, Late Onset Retinal 
Degeneration (Folwell et al.) and Dominant Drusen (Milam et al., 2000). Most recently 
Loeffler and Lee have suggested that the term basement membrane deposit (BMD) be used 
instead of BlamD (Loeffler and Lee, 1998). As BlinD had become an orphan term, it was 
subsequently reintroduced by Green and Enger to describe the diffuse deposit that 
accumulates external to the RPE basement membrane (Green and Enger, 1993).  
 
2.2.2 Subclinical deposit external to the RPE basement membrane 
BlinD consists primarily of a diffuse collection of membranous debris located between the 
RPE basement membrane and the inner collagenous layer of BM. BlinD was initially 
described using light microscopy as lipid-like vesicles with varying diameters, as the 
membranous collections themselves were not visible (Sarks et al., 1980). The material has 
subsequently been shown to be comprised primarily of lipoprotein particles containing 
neutral lipids, including esterified cholesterol (Curcio et al., 2005; Sarks et al., 2007; Sarks et 
al., 1980). Imaged by electron microscopy, these fragments appear to be released from the 
basal surfaces of the RPE in blebs, analogous to the shedding of outer segment discs by the 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
16 
 
photoreceptors (Sarks et al., 1988). This material is deposited in layers, a little scattered 
within BlamD, whilst the majority is between the RPE basement membrane and the inner 
collagenous layer of BM, forming BlinD. Focal accumulation of membranous debris result in 
basal mounds, and the degree of membranous debris appears to influence the course of 
disease (Sarks et al., 2007). Basal mounds do not appear until BlamD have thickened 
sufficiently, indicating that membranous debris and early BlinD continue to develop 
together. As the mounds enlarge and fuse together, the RPE cells show progressive 
dysfunction and eventually die. The accumulation of this material is thus dependent upon a 
ready source of material, photoreceptor outer segment, and processing machinery - the 
RPE. In the absence of either of these, membranous debris will not accumulate. 
Membranous debris formation may also be thought of as an additional stress response; non-
apoptotic cell blebbing has been observed in RPE cells cultured in vitro when exposed to 
stressors (Malorni et al., 1991; Marin-Castano et al., 2005).  
 
2.2.3 Subclinical deposit within the RPE  
In addition to being found external to the RPE basement membrane, membranous debris 
also accumulate inside the RPE cells within vacuoles, and at the apical surface (Sarks et al., 
1988).  
 
2.2.4 Subclinical deposit internal to the RPE apical membrane (between the RPE 
and photoreceptors)  
A photoreceptor-derived source for subretinal deposit was first proposed by Sarks, as the 
membranous debris disappear when the photoreceptors undergo atrophy (Sarks et al., 
1988). Others have contested this, suggesting that the filipin fluorescence of the sub-retinal 
debris is much higher than that seen in photoreceptor outer segments, and that the deposit 
lacks immunoreactivity for key photoreceptor proteins (GFAP, opsin) (Curcio et al., 2005). It 
is possible however that significant outer segment processing takes place, accounting for the 
difference in composition. Indeed in vitro work has confirmed that the removal of 
phospholipid elevates the cholesterol concentration from that found in native outer 
segments to the level expected in subretinal deposit (Kruth, 1985; Skarlatos et al., 1993). 
Alternatively apical extrusion of material with a slightly different composition may represent 
a separate consequence of RPE stress. 
 
2.2.5 Summary of subclinical responses 
Subclinical changes therefore set the scene for the future phenotype. Progressive BlamD 
accumulation indicates one cellular response to stress, which eventually may manifest as 
RPE hyperplasia and atrophy, and occurs in the absence of soft drusen. Membranous debris 
accumulation represents a second way in which the RPE responds to stress, and the 
direction (apical versus basal) and magnitude of this reaction determines the clinical signs. If 
the debris accumulates internal to the RPE as a result of apical movement, subretinal 
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deposit rather than conventional drusen form. RPE dysfunction may additionally 
compromise photoreceptor outer segment phagocytosis, adding to the accumulating 
deposit. If the debris extends into BM from the basal RPE surface via a separate mechanism, 
soft drusen form. Historically this has been considered the hallmark of AMD and may 
represent one consequence of the para-inflammatory process (Xu et al., 2009).The patterns 
of RPE response to stress are therefore likely to determine the clinical signs that later 
develop – RPE atrophy and hyperplasia, soft drusen formation and subretinal drusenoid 
deposit.  
 
2.3 Complement and drusen 
Proteins of the complement system have long been identified as key druse components 
(Baudouin et al., 1992; van der Schaft et al., 1993) and the complement cascade is thought 
to be activated by the products of visual cycle (Anderson et al., 2010). Retinoids 
accumulating inside the RPE are inaccessible to proteins of the complement cascade, 
however once externalised they are free to interact with the various forms of C3, and these 
locally deposited activation products (C3a, C3b, C3dg) then serve as ligands for leukocyte 
receptors (Anderson et al., 2010). Drusen also contain the regulatory protein CFH. 
Histological studies have been followed by genetic endeavours, aiming to identify risk 
factors for AMD. In 2005 four groups independently reported a significant association 
between AMD and a common variant (rs1061170) in CFH (Edwards et al., 2005; Hageman et 
al., 2005; Haines et al., 2005; Klein et al., 2005). This variant (Y402H) is associated with 
functional consequences, as it limits the binding of CFH to various complement-activating 
targets, reducing its inhibitory activity and thus prolonging the activity of C3 convertase 
(Herbert et al., 2007; Laine et al., 2007). Other rare variants in CFH have also been reported 
(R1210C, R53C and D90G) (Raychaudhuri et al., 2011; Yu et al., 2014). R1210C is extremely 
rare, with a minor allele frequency of 0.0173% (ExAC database accessed 16.11.15), but has 
an even stronger association with AMD than Y402H, perhaps acting as a functionally null 
allele (Raychaudhuri et al., 2011). R1210C is also associated with atypical hemolytic uremic 
syndrome (OMIM 134371). The drusen phenotype associated with the R1210C risk allele has 
recently been described (Ferrara and Seddon, 2015). The authors identified widespread soft 
drusen, both at the macular and outside the arcades, an unusual combination as such 
drusen are rarely observed in the peripheral retina. It is plausible that a spectrum of 
polymorphisms in CFH, CFB, CFI C2, C3 and C9 all contribute to drusen biogenesis, with 
additional stimuli arriving from exogenous factors such as smoking. Identifying alleles of low 
penetrance, acting in a complex (oligogenic) manner will be difficult. Studies designed to 
enrich for more highly penetrant alleles, by recruiting extreme phenotypes e.g. “young-
onset AMD”, will help. 
 
3. Clinically detectable deposits (seen in ageing and AMD) 
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Historically the assessment of drusen has relied on either clinical examination or the 
evaluation of colour fundus photographs and this technique has produced the widely used 
Wisconsin Age-Related Maculopathy Grading System, the International Classification system 
and the AREDS (Age-related Eye Disease Study)  classification system (Bird et al., 1995; Davis 
et al., 2005; Klein et al., 1991). These systems yield the terms, “hard drusen”, “intermediate 
drusen”, and “soft drusen” (the latter often used synonymously with “large drusen”). This is 
predominantly, and somewhat arbitrarily, based on size: hard drusen are smaller than 63 μm 
(this diameter corresponding to half the width of a large vein at the optic disc margin); 
intermediate drusen are 63-125 μm; soft (‘large’) drusen are larger than 125 μm. A 
classification based purely on size however will miss the fact that small soft drusen exist, and 
consequently will report them as hard drusen. Similarly, cuticular drusen, which are also 
small in size, may be simply classed as hard drusen if graded from photographs alone.  
In a more recent clinical classification scale (Ferris et al., 2013), individuals over 55 years of 
age with small (<63 μm) drusen were considered to have normal ageing, with the term 
“drupelets” also suggested for these lesions. Those with medium drusen (63-125 μm) and no 
pigmentary abnormalities were classified as early AMD. Those with larger drusen, or with 
pigmentary abnormalities associated with medium drusen, had intermediate AMD (see 
Figure 2). Individuals had late AMD if they had neovascular AMD or geographic atrophy. 
The risk of developing late AMD increases with increasing drusen size and also with the 
presence of pigmentary abnormalities. If lesions are present in both eyes, the risk increases 
further. Ferris et al. (2013) summarised previous AREDS data to provide the five-year rate of 
developing advanced AMD for different lesion types (see their Table 1). In the absence of 
pigment abnormalities in either eye, the rate of developing advanced AMD was 0.4% in 
subjects with no drusen or small drusen only. The rates were 0.5% and 2.1% for subjects 
with intermediate drusen in one eye or both eyes respectively; these rates increased 
respectively to 3.9% and 13% for large drusen. If pigmentary abnormalities were also 
present in both eyes, the rates risks increased significantly: for subjects with intermediate 
drusen in one or both eyes, the rates were 12.9% and 20% respectively; for large drusen, the 
rates were 25.6% and 47.3% respectively. In addition, the presence of reticular 
pseudodrusen (Section 3.5) appears to be have prognostic significance: Zhou et al. (2016) 
recently showed, from analysis of fellow eyes in the Comparison of Age-Related Macular 
Degeneration Treatment Trials, that pseudodrusen were associated independently with a 
higher risk of advanced AMD; in particular, dot pseudodrusen were associated with 
neovascular AMD whilst confluent pseudodrusen were associated with geographic atrophy.  
The incidence and prevalence of different drusen subtypes is known to vary between 
populations. When participants of the Blue Mountains Eye Study and the Singapore 
Epidemiology of Eye Disease Study were compared (Joachim et al., 2014), age-standardised 
prevalence of distinct soft drusen was significantly higher in Singaporeans compared to 
Australians whilst indistinct soft drusen and reticular drusen were more prevalent in 
Australians. In addition, Australians were more likely to have soft drusen in the central 
macula. Fisher et al. (2016) recently described incidence of AMD in different ethnicities 
residing in the United States from the Multi-Ethnic Study of Atherosclerosis cohort (3811 
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participants aged 46 to 86). The overall 8-year age- and sex-standardized incidence was 4.1% 
for early AMD and 2.3% for late AMD. Incidence of early and late AMD respectively in 
different ethnicities was as follows: 5.3% and 4.1% in whites; 4.5% and 2.2% in Chinese; 
3.3% and 0.8% in Hispanics; black participants had the lowest incidences (1.6% and 0.4%). 
For the combined group as a whole, previously described AMD risk factors, namely age, 
ethnicity, current smoking, hyperopia, and AMD-susceptibility genotypes Complement 
Factor H (CFH) RS1061170 and Age Related Maculopathy Susceptibility 2 (ARMS2) 
RS3793917 were independently associated with incident early AMD. Interestingly, Chinese 
subjects had a greater incidence of drusen greater than 125 micrometres in diameter than 
whites (10.9 vs 8.4%) and greater incidence of soft distinct drusen (18.4% vs 11.9%); white 
subjects on the other hand had greater incidence of soft indistinct drusen than Chinese 
subjects (5.8% vs 3.8%), whilst both ethnicities had equal incidence (3.3%) for drusen area 
greater of 500 square micrometres or greater (Fisher et al, 2016).  
In the following section we shall discuss, in some detail, the varied phenotypes associated 
with drusen and drusenoid deposits. Historically, specific drusen subtypes have been 
associated with only one or two pathological processes; however, as more detailed 
descriptions of the rarer retinal phenotypes are reported we are beginning to appreciate 
that these deposits may represent a final common pathway for divergent pathological 
processes. As AMD is the most commonly encountered disease associated with drusen most 
of the clinical studies referenced will relate to AMD; however, that is not to say the 
phenotype being described is only seen in that condition.  
Hard and soft drusen will be considered first as they are the most commonly encountered. 
Cuticular drusen, a specific sub-type of small drusen, will then follow. Following the 
discussion of these conventional drusen phenotypes will be a short description of refractile 
or calcified drusen (Section 3.4), as calcification may be a feature of all drusen.  
Focal deposits, accumulating between the outer retina and RPE (subretinal drusenoid 
deposit (SDD), also termed reticular pseudodrusen (RPD)), often observed alongside other 
forms of conventional drusen will then be discussed. In each case, appearance on colour 
photography will be discussed, followed by histological features, aiming to provide context 
to the clinical signs. Characteristic features seen on other forms of imaging, both non-
invasive (spectral domain OCT and SWAF) and invasive (fluorescein and indocyanine green 
angiography) will be presented, as well as, in the case of RPD, the addition of a section 
describing appearance and insights revealed from multimodal reflectance imaging. Although 
not truly drusen (which are deposits located immediately external to the RPE), they share 
many features with them.  
Table 2 summarises the imaging features of the drusen subtypes. Most of the drusen are 
features of ageing or age-related maculopathy, although cuticular drusen may be seen in 
younger subjects. In the final part of this section, we discuss other structures identified on 
OCT that have been termed outer retinal corrugations, hyperreflective pyramidal structures 
and “ghost drusen” (Section 3.6).  
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Table 2. Features of different drusen sub-types on retinal imaging. Near infra red 
reflectance imaging (not included) is particularly useful for identifying reticular 
pseudodrusen (see text). 
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 Small Drusen Large Drusen  Subretinal deposit 
Hard drusen Cuticular drusen Soft drusen Reticular 
pseudodrusen  
Colour 
fundus 
photography  
(CFP) 
Small (<63 μm) 
discrete yellow-
white deposits 
with distinct 
edges. Found in 
macula and 
peripheral retina.  
Numerous (>50) 
small (25-75 μm) dot-
like deposits in 
macula and 
peripheral retina 
(may be more 
numerous in 
periphery, and first 
visible here). Early 
stages not readily 
detectable on CFP. 
Larger (usually >125 
μm) less discrete 
deposits found only in 
the posterior pole 
(more frequent in 
central macula, superior 
and temporal 
quadrants). Yellow 
appearance; central 
part may be whiter. 
Variable diameter (c. 
100 μm); may be dot-
like or reticular. Found 
preferentially in the 
perifovea (often more 
predominant 
superiorly). Whiter 
and more irregular 
than conventional 
drusen. Near infrared 
CSLO reflectance 
imaging is more 
sensitive than CFP.  
Short 
wavelength 
auto-
fluorescence 
Foci of reduced AF 
sometimes 
surrounded by 
increased AF 
Hypoautofluorescent 
dots. May appear 
larger than on CFP 
(although CFP may 
be more sensitive). 
Moderate 
hyperautofluorescence. 
Larger drusen may 
show heterogenous AF 
signal. 
Reticular pattern, 
hypoautofluorescent. 
A minority may be 
atypically 
hyperautofluorescent. 
OCT Small sub-RPE 
deposits, 
hyperreflective. 
Sometimes less 
discernible than 
on colour fundus 
photography. 
Sub-RPE. Prolate 
shape, moderate 
hyperreflectivity. 
Saw-tooth 
configuration. Larger 
drusen erode into 
the RPE monolayer; 
apex only thinly 
covered by RPE. 
Larger sub-RPE 
deposits, 
hyperreflective. 
Deposits between the 
RPE and inner 
segment ellipsoid lines 
(stages 1 and 2), later 
breaking through the 
ellipsoid line (stage 3) 
and subsequently 
fading (Stage 4). Light 
stripes may be visible 
in the underlying 
choroid. 
Fundus 
fluorescein 
angiography 
Possible mild 
hyperfluorescence 
“Starry sky” 
appearance: densely 
distributed 
hyperfluorescent 
dots. Earlier lesions 
not visible (but seen 
on AF). 
Variable, usually some 
late hyperfluorescence. 
Hypofluorescence or 
no change 
Indocyanine 
green 
angiography 
Hyperfluorescent Early 
hyperfluorescence 
Hypofluorescent Hypofluorescence in 
mid to late-phase. 
 
Although not a primary focus of this review, mention will be made in some of the following 
subsections of neovascular complications. Neovascularisation (associated frequently, but not 
exclusively, with AMD) has been classified as type 1 (below the RPE), type 2 (above the RPE, 
in the subretinal space) and type 3 (also termed retinal angiomatous proliferation), with SD-
OCT being the imaging modality most suited to establishing this distinction in vivo Type 1 
membranes appear most likely to be associated with drusen or the subclinical deposits 
mentioned in the Section 2; a recent histopathological study confirmed the presence of 
basal laminar deposits in type 1 neovascularisation (Curcio et al., 2015). Other types may 
develop in absence of drusen or may be associated with the presence of subretinal 
drusenoid deposit (Freund et al., 2010).  
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3.1 Hard drusen 
3.1.1 Colour fundus photography of hard drusen 
Hard drusen are defined as discrete yellow-white deposits sited underneath the RPE. They 
are small, with a diameter of less than 63μm, have sharply defined edges and uniform colour 
density from their centre to edge (Age-Related Eye Disease Study Research, 2001; Bird et al., 
1995). Figure 2 shows imaging from an AMD patient with hard and soft drusen. Small, hard 
drusen are common with a prevalence of 93.6% in subjects aged 43 to 86 years in the Beaver 
Dam Eye study. Hard drusen are the only drusenoid deposits that are considered a normal 
consequence of age (Rudolf et al., 2008a), though AMD frequently begins with hard drusen.  
Widefield photography is particularly useful for identifying the distribution of drusen 
throughout the retina. Hard drusen are widespread, and are found throughout the 
peripheral (outside the vascular arcades) as well as central retina. Hard drusen may also be 
more visible than other drusen despite their small size, as they are often refractile.  
 
3.1.2 Histology of hard drusen 
In a recent analysis of druse subtypes, Rudolf and colleagues categorised drusen based on 
histological appearance (Rudolf et al., 2008a). Deposits that were round, with sharply 
demarcated borders filled with homogeneous hyalinised material were called hard drusen. 
They have an eosinophillic, amorphous appearance and are PAS positive, shared by other 
drusen types, but are significantly more compact structures than soft drusen. In comparison 
with other druse types, hard drusen, both at the macula and in the periphery were 
associated with a loss of overlying RPE cells. Centrally located hard drusen were also found 
to be larger, associated with a thicker BlamD and had a more heterogenous substructure 
with more amyloid assemblies (concentric ring like structures of β-amyloid) than peripheral 
hard drusen. In addition, macular hard drusen tend to calcify more readily than peripheral 
drusen. Hard drusen do share similarities with soft drusen, as both selectively accumulate 
proteins, some of which may be plasma derived (amyloid P component, prothrombin) whist 
others are more likely to be locally secreted (vitronectin, complement proteins C3, C5, and 
C9, and apolipoproteins B and E) (Anderson et al., 1999; Osusky et al., 1997; Ozaki et al., 
1999).  
 
3.1.3 OCT of hard drusen 
Whilst OCT has been effectively used to help classify drusen there has been relatively little 
published on the characteristics of hard drusen, as researchers have preferred to 
concentrate on subtypes with a stronger disease association. Khanifar and colleagues 
described 17 morphological druse patterns on OCT imaging, broadly separating deposits 
based on shape, reflectivity and internal consistency (Khanifar et al., 2008). An important 
finding when they attempted to correlate photographic findings (hard, soft, calcific or 
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reticular drusen) with OCT findings was that no one druse type had a specific OCT signature. 
Interestingly, the authors were unable to identify any hard drusen in their photographs, 
unusual for eyes with AMD. For small, flat hard drusen, however, colour fundus photography 
might be more sensitive than OCT, as yellow on red colour discrimination over a druse 
diameter may be more readily discernible than a separation of highly reflective lines on OCT 
representing BM and the RPE.  
 
3.1.4 Fundus autofluorescence of hard drusen 
In 2000 Delori and colleagues reported a novel pattern of druse autofluorescence consisting 
of decreased AF in the centre of the druse surrounded, in most cases by an annulus of 
increased AF (Delori et al., 2000). The dark central focus of the AF pattern is not black, but is 
as much as 30% lower than the surrounding background (Delori et al., 2000). The reduction 
in AF was however not thought to be due to RPE melanin as monochromatic imaging 
showed no evidence of melanin absorption (Delori et al., 2000). Several explanations were 
then proposed, primarily relating to the number of lipofuscin granules in the overlying RPE. 
The authors reported that hard and soft drusen (between 60 and 175 μm in size) are 
characterised by foci of reduced autofluorescence that may or may not be surrounded by an 
annulus of increased autofluorescence. Irregular areas of low AF can be observed in large 
drusen, consistent with the idea that they develop as a result of fusion of smaller hard or 
soft drusen (Delori et al., 2000).  
 
3.1.5 Fluorescein angiography of hard drusen 
Hard drusen may show mild hyperfluorescence on fundus fluorescein angiography (FFA). 
Hyperfluorescence may also be seen on indocyanine green angiography (ICGA). Fluorescein 
binding correlates more with the biochemical composition of drusen rather than size: 
deposits with a high content of phospholipids bind more fluorescein, and tend to have high 
proportions of fibronectin; deposits with higher proportions of neutral lipids show less 
fluorescein binding (Pauleikhoff, Zuels et al., 1992).  
 
3.2 Soft drusen 
3.2.1 Colour fundus photography of soft drusen 
In terms of x-y location, soft drusen are only found at the posterior pole of the fundus, more 
frequently in the central macula, and in the superior and temporal quadrants of the macula 
(Wang, Chappell et al., 1996; Knudtson, Klein et al., 2004). They appear less well demarcated 
than hard drusen (Figure 2), as mound-like elevations, usually ≥ 125μm in diameter but on 
occasion smaller. The central portion of the druse may appear whiter than its yellow edge 
(Spaide and Curcio 2010). Soft distinct drusen have a uniform density whereas soft indistinct 
drusen have a graded density from their centre to periphery with blurred edges. 
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Figure 2. Retinal imaging from the left eye of an 84-year old man with AMD. A, colour 
photograph shows multiple drusen of varying size (small, medium and large) as well as 
pigmentary change. B, Short-wavelength AF image shows variable hyper- and hypo-
autofluorescence. C, Horizontal OCT scan with corresponding infrared reflectance image 
showing OCT appearance of large and small drusen.  
 
3.2.2 Histology of soft drusen 
Soft drusen are low mounds that can be connected by basal linear deposit. They are only 
found at the posterior pole. RPE coverage (number of overlying cells) does not seem to be 
reduced over soft drusen, although their morphology and pigmentation may be affected 
(Rudolf et al., 2008). Both soft drusen and BlinD are filled with ‘membranous debris’, 
appearing as coiled membranes and vesicular outlines (Rudolf et al., 2008a; Sarks et al., 
1988). Membranous debris has also been referred to as ‘lipoprotein derived debris’ aiming 
to reflect the high esterified cholesterol content in these lesions, whilst retaining the 
possibility that shed cellular membranes do appear in drusen (Wang et al., 2009a). This 
debris appears to comprise solid particles rich in neutral lipid (Curcio et al., 2005). Soft 
drusen contain significant pools of esterified cholesterol and as a result it has been 
suggested that soft drusen record a higher cholesterol content and lower lipoprotein 
content than hard drusen (Malek et al., 2003). Consequently both soft drusen and BlinD are 
easily disrupted, and do not survive chemical processing well. It has been hypothesized that 
the presence of separation between the RPE basement membrane and the inner 
collagenous layer of BM by such material may facilitate the spread of choroidal 
neovascularisation within this cleavage plane, possibly helping explain the association 
between soft drusen and advanced AMD.  
 
3.2.3 OCT of soft drusen 
Soft drusen are seen as mound-shaped, moderately hyperreflective elevations of the RPE on 
OCT of varying size. The thickness does not seem to correlate with the colour on fundus 
photography (Spaide & Curcio, 2010). Overall druse size however seems to be very similar 
between the two modalities (Jain et al., 2010). At the extremes of size, small drusen appear 
easier to detect using colour fundus photography whilst larger drusen may be more 
accurately sized with OCT due to better visualisation of their boundaries (Jain et al., 2010). 
As soft drusen and BlinD represent two forms of the same AMD lesion, they display a 
dynamic relationship that may be visualised with detailed retinal imaging. Despite 
appreciating such changes, their evolutionary course is not predictable, as sequential OCT 
imaging studies have identified a range of endpoints (minimal change, drusen regression, 
increase in number of drusen, outer retinal atrophy, neovascularisation) from similar 
starting points (Yehoshua et al., 2011). 
 
3.2.4 Fundus autofluorescence of soft drusen 
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As first reported by Delori and colleagues, on autofluorescence imaging the edges of some 
soft drusen appear slightly hyper-autofluorescent as compared with the central portion 
(Delori 1999). This is more easily visualised using a fundus camera based system than CSLO. 
This might be related to the different excitatory wavelengths of the two systems 
(approximately 530-580 nm for camera based system; 488 nm for CSLO).  
  
3.2.5 Fluorescein angiography of soft drusen 
Soft drusen can show varying levels of fluorescence, although usually they show some 
evidence of late hyperfluorescence. Hypofluorescence may be seen on ICGA. Fluorescein 
binding relates to the balance between neutral and polar lipids as mentioned earlier. 
 
3.3 Cuticular drusen 
These are multiple small drusen that may cluster, and were first described with reference to 
their characteristic “starry sky” appearance on fluorescein angiography (Section 3.3.5). They 
are most strongly associated with AMD, but also dense deposit disease (type 2 
membranoproliferative glomerulonephritis/C3 glomerulonephritis/C3 nephropathy) 
(McAvoy and Silvestri, 2005) and causative variants in the gene CFH (Complement Factor H) 
(Boon et al., 2008). They are a type of small, hard, early onset drusen, and have also been 
termed basal laminar drusen, though it has been suggested that the latter term is a 
misnomer (Russell et al., 2000). Figure 3 shows imaging from a patient with cuticular drusen. 
 
Figure 3. Images from the right eye of a 47 year-old man with cuticular drusen. A, Colour 
fundus photograph showing drusen and pigmentary change. B, Fundus fluorescein 
angiogram (at 27 seconds after dye injection) showing the characteristic “starry sky” 
appearance. C, Short-wavelength AF showing a mixture of hypo and hyper-
autofluorescence. D, Horizontal enhanced depth OCT scan with corresponding infrared 
reflectance image. 
 
3.3.1 Colour fundus photography of cuticular drusen 
Cuticular drusen are numerous (>50), small (25-75um), round, dot-like drusen that densely 
populate the retina (Gass, 1977). They occur both in the macula and peripheral retina. In the 
periphery they may be even more numerous, and occur in regions with senile reticular 
pigmentary change (Boon et al., 2013; Gass, 1977; van de Ven et al., 2012). The periphery is 
also the site where cuticular drusen are often first visible (Boon et al., 2013). Individually 
they may be mistaken for hard drusen, and it is their occurrence in such large numbers that 
facilitates identification on colour fundus photography. Over time, as drusen accumulate, 
individual drusen may eventually coalesce, and they can also be mistaken for soft drusen at 
this stage. Clinical detection is otherwise difficult since the lesions are not associated with 
abnormal pigmentation, at least not until late on, and so are of low contrast against the RPE. 
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Their low elevation similarly does not allow lesions to be distinguished stereoscopically. As a 
result colour fundus photography is not sufficiently sensitive at identifying cuticular drusen, 
particularly in their early stages. Larger lesions may be detected with red-free photography 
or infrared reflectance imaging with a CSLO, as both modalities enhance contrast with the 
RPE. 
 
3.3.2 Histology of cuticular drusen 
Histological analysis followed the initial clinical description of cuticular drusen. Using both 
light and electron microscopy, diffuse and nodular thickening of the inner portion of BM was 
identified. The thickening was associated with accumulation of vesicular and curvilinear 
membranous profiles and basement membrane-like material, apparently derived from the 
RPE (Kenyon et al., 1985).  Gass proposed that these drusen were actually focal nodular 
thickenings of the RPE basal lamina; a hypothesis that was later challenged by Russell and 
colleagues (Gass et al., 1985; Russell et al., 2000). They argued that cuticular drusen were 
cellular aggregations (carbohydrates, lipid and protein) located between the basal lamina of 
the RPE and the inner collagenous layer of BM (Russell et al., 2000). The identified genetic 
associations are in keeping with a role of parainflammation (variants in CFH, CFI) (Boon et 
al., 2008; Grassi et al., 2007; Seddon et al., 2009; van de Ven et al., 2012) and ECM 
dysregulation (Albig and Schiemann, 2005; Mullins, 2007; Nguyen et al., 2004; Stone et al., 
2004), which supports the view that alterations in BM anatomy or function contribute to the 
formation of cuticular drusen.  
 
3.3.3 OCT of cuticular drusen 
In cross-section cuticular drusen have a prolate shape, with moderate hyperreflectivity. As 
the basal diameter for many cuticular drusen is about the same as their height they assume 
a saw tooth configuration in SD-OCT examination (Spaide and Curcio, 2010). Larger cuticular 
drusen seem to erode into the RPE monolayer and so the apex of each cuticular druse has 
only a thin covering of pigment epithelium. These RPE changes may reverse as drusen 
regress (van de Ven et al., 2012). Cuticular drusen have been associated with AMD and 
pseudovitelliform macular detachment, with one study suggesting that neovascularization is 
present in up to one third of eyes (Boon et al., 2013; Cohen et al., 1994; Gass et al., 1985). 
Others have described subretinal fluid in the absence of CNVM, attributed to loss of RPE 
function and have therefore cautioned against the injudicious use of anti-VEGF therapy 
(Cohen et al., 1994; Pilli et al., 2011). It appears therefore that in the advanced stages, the 
presence of significant coalesced cuticular drusen also implies widespread loss of RPE 
function.   
 
3.3.4 Fundus autofluorescence of cuticular drusen 
Recently Meyerle and colleagues have compared the appearance of cuticular drusen using 
different imaging modalities (Meyerle et al., 2007). Small “early” cuticular drusen that have 
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not eroded through the RPE tend not to be visible by FFA but are identifiable by AF, as 
discrete hypoautofluorescent dots (Meyerle et al., 2007). Larger lesions tend to have a 
similar appearance (but fluoresce after dye injection). Occasionally, as individual drusen 
merge forming larger deposits, they may exhibit greater autofluorescence levels. When 
drusen are compared using colour photography and AF, they appear larger in the AF images, 
suggesting that only the centre of the druse is identified with white light (Meyerle et al., 
2007). 
 
3.3.5 Fundus fluorescein angiography of cuticular drusen 
These drusen were first recognised by their “starry sky” appearance on FFA, a reference to 
the multitude of densely packed hyperfluorescent deposits (Gass, 1977). Cuticular drusen 
fluoresce brightly from their apices, probably as a result of focal erosion of the overlying RPE 
and consequent window defect into the choriocapillaris. Less mature drusen do not possess 
this property. As expected, their fluorescence (of choroidal origin) begins earlier in the 
angiogram than is seen with other drusen. The alternative hypothesis, that the bright 
fluorescence results from a uniquely hydrophilic core, is perhaps less likely, as 
ultrastructurally cuticular drusen appear similar to other types of drusen (Russell et al., 
2000). On ICGA, early hyperfluorescence is seen. 
 
3.4 Calcified drusen 
The finding (described in Section 2.1) of hypdroxyapatite spherules in all types of subretinal 
deposits (Thompson et al., 2015) suggests that all drusen are calcified, just to differing 
extents. The more calcified deposits appear phenotypically different, however, from those 
with lower calcium content. Suzuki and associates have investigated this performing 
multimodal imaging on 10 eyes (Suzuki et al., 2015). They report that calcified drusen are 
hypoautofluorescent, although this varied with the deposit location, with central calcific 
drusen casting a larger hypofluorescent shadow than the peripherally placed drusen. They 
also identified hyperautofluorescent “conventional” drusen located peripheral to calcified 
drusen. Imaging these lesions with SD-OCT demonstrated that the calcified drusen have a 
heterogeneous internal hyperreflectivity, with dots and curvilinear structures. Alongside 
these clinical signs the authors were additionally able to describe histological changes in 19 
calcified drusen from 6 donor eyes. All contained mineral deposits consistent with calcium. 
The overlying RPE was disrupted in all but two cases and most were associated with 
morphological changes in the photoreceptor outer segment. In addition, some drusen also 
contained Müller cell processes, RPE cells, or macrophages (Suzuki et al., 2015).  
Calcification is likely to be vital for drusen formation, with levels of calcium changing 
throughout their lifecycle. As drusen eventually regress, with increasing chronicity, their 
calcium content may increase. All drusen are thought to contain some calcium, perhaps 
essential for formation, and as such calcific drusen are not a unique type of drusen; rather, 
calcification may correlate with druse age.  
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3.5 Reticular pseudodrusen (RPD) 
In 1990 Mimoun et al. coined the phrase “pseudodrusen visible en lumière bleue” 
(pseudodrusen visible with blue reflectance fundus photography) to describe retinal lesions 
with a variable diameter of about 100 microns that did not appear hyperfluorescent on 
fluorescein angiography (Mimoun et al., 1990). They were considered a variant of 
conventional drusen and thought to arise from below the RPE. Accordingly, a year later, 
these deposits were then included in the Wisconsin age-related maculopathy grading system 
as “ill-defined networks of broad, interlacing ribbons” and Klein referred to them as reticular 
drusen (Klein et al., 1991). No comment was made regarding their significance however. 
With the advent of newer imaging techniques, the original conclusions were questioned and 
the nomenclature of this drusen type changed. Smith et al. introduced the term “reticular 
macular disease” and Zweifel et al. favoured the term “subretinal drusenoid deposits” (SDD) 
(Smith et al., 2009; Zweifel et al., 2010). Others debate whether reticular pseudodrusen are 
indeed the same entity as subretinal drusenoid deposit, citing disparity between the two 
when different imaging modalities are used (Grewal et al., 2014; Sohrab et al., 2011). Whilst 
co-registration error is a plausible explanation, studies designed to account for this still 
suggest that RPD and SDD may not be topographically identical (Heiferman et al., 2015). 
Here we will review the characteristic features of these lesions as we currently understand 
them. We choose to use the historical term RPD when referring to signs of ageing/AMD, and 
SDD in reference to non-AMD pathology, as the latter simply refers to the anatomical 
location in which a variety of deposit may accumulate, in association with a range of 
diseases. It remains to be definitively determined if RPD are a subtype of SDD or in fact the 
same lesion.  
 
3.5.1 Colour fundus photography of reticular pseudodrusen 
RPD were first identified with blue light photography (Mimoun et al., 1990). On colour 
images, RPD may appear as either dot-like or reticular deposits, more blue, or at least 
whiter, than conventional soft drusen. Unlike soft drusen, which have a predilection for the 
foveal region, RPD are most often first noted in the upper part of the macula sparing the 
fovea. As they spread outwards the gaps in the network narrow and ultimately the deposits 
become unrecognisable, producing a featureless yellow or yellow-grey background. RPD also 
fade around neovascular membranes and hence they have been considered a transient 
phenomenon; extramacular RPD however are often more stable in appearance.  
Generally the en face appearance of individual RPD is more irregular, sinusoidal or ring 
shaped compared to the typical round shape of conventional drusen. Despite this they tend 
to have a uniform pattern across a large retinal area, in contrast to other drusen that are 
more randomly distributed. RPD tend not to be associated with co-existing pigmentary 
change. Whilst conventional drusen can abut the optic nerve, RPD appear not to do so, and 
extend only as far as the RPE edge. The fact the central fovea and peripapillary retina, both 
cone rich regions, are spared may be significant for theories of RPD biogenesis. RPD also 
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appear larger in colour images when compared to near infrared reflectance (NIRR) images. 
Suzuki et al. have recently shown that the ribbon subtype of RPD are more easily identifiable 
on colour photography compared with infrared reflectance (Suzuki et al., 2014). The high 
specificity of blue wavelength and red-free light for reflective deposits above the RPE may 
be in part due to the high absorbance of blue light by RPE melanosome, increasing the 
contrast between reticular lesions and the darker background. Despite good specificity, 
monochromatic blue and red-free light offer low sensitivity as they are highly affected by 
media opacity. The appearance of RPD on confocal scanning laser ophthalmoloscopy 
(Macauley et al.) will be described subsequently. 
 
3.5.2 Histology of reticular pseudodrusen 
Location (Z axis) 
Prior to their clinical recognition subretinal deposit had been identified histologically. Sarks 
et al used low magnification transmission electron microscopy (TEM), to show well 
organized, spherical, and homogeneous aggregations of membranous debris (Sarks et al., 
1988). These deposits were only present where photoreceptors co-existed. Following on 
from the original clinical description, Arnold et al. were the first to correlate clinical findings 
with histological changes (Arnold et al., 1995). They analysed images from 100 patients with 
reticular pseudodrusen retrospectively, and performed a histological examination in a single 
eye with early stage disease. They were able to confirm that pseudodrusen did not 
correspond to the accumulation of basal laminar or basal linear deposit, nor with 
conventional drusen, and speculated that the reticular pattern correlates with the lobular 
choroid anatomy, identifying selective loss of the middle choroidal small vessels. They 
concluded by proposing that RPD originate as a primary choroidal disease, manifest as 
vascular attenuation and reticular fibrosis, and proposed the term “reticular pseudodrusen” 
(RPD) (Arnold et al., 1995). The RPD themselves however were not identifiable within the 
sections (as the retina was missing) and the authors had to infer their location from clinical 
observations, potentially weakening their correlative conclusions. Sixteen years later, the 
same group were able to perform a more complete histological retinal examination, again of 
a single eye with RPD, however this time they were able to identify subretinal deposition of 
membranous deposit. They concluded that the RPD phenotype resulted from material 
collecting internal to the RPE (Sarks et al., 2011).  
 
Location (X-Y) 
RPD are found preferentially at a perifoveal location. Within the perifovea, the superior 
retina appears to be more severely affected (Curcio et al., 2013). BlinD in contrast is thickest 
at the fovea, where cones are maximally dense (Curcio et al., 2013). These anatomical 
differences suggest that RPD and BlinD may reflect differences in rod and cone physiology. 
Where RPD and BlinD do show topographical overlap, they tend not to appear on opposite 
aspects of the same RPE cells (Curcio et al., 2013). In recent imaging studies, RPD have been 
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shown to follow the choroidal vasculature, supporting a role for the choroid in their 
aetiology as previously postulated (Grewal et al., 2014). 
Composition 
Postmortem studies have identified that RPD share superficial ultrastructural and 
compositional similarities with soft drusen. These include the presence of membranous 
vesicles, membrane-bounded particles with neutral lipid interiors, unesterified cholesterol 
(UC), apolipoprotein E (apoE), complement factor H, and vitronectin (Rudolf et al., 2008b). 
The same material has also been identified enclosed within RPE intracellular vacuoles and so 
it has been suggested that these vacuoles eventually release their contents, forming 
conventional drusen at the basolateral RPE surface or RPD if released from the apical surface 
(Curcio et al., 2013; Curcio and Millican, 1999; Curcio et al., 2005; Sarks et al., 1988; Sarks et 
al., 2007). It is quite conceivable that a metabolically stressed RPE cell may lose its polarity, 
resulting in material deposition on its internal rather than external surface. The fact that 
BlinD and RPD tend not to occur on either side of the same cell is in keeping with this 
hypothesis. RPD however do differ from drusen in some constituents, and have low levels of 
apoB, apoA-I, and esterified cholesterol, thought to represent components of an RPE-
produced lipoprotein (Li et al., 2006). RPD were also thought to lack immunoreactivity for 
photoreceptor, Müller cell, and RPE marker proteins (Rudolf et al., 2008b). However Sarks et 
al. have identified components of disorganized and undigested photoreceptor outer 
segment in the same specimens as RPD (Sarks et al., 2011). The compositional differences in 
RPD and BlinD may in fact reflect physiological differences between photoreceptors; rod 
outer segment disc membranes have very low concentrations of unesterified cholesterol in 
comparison to cone disc membranes (invaginations of the plasma membrane). To 
compensate rod outer segment membranes increase their content of the fatty acid 
docosahexaenoate (DHA). RPE cells that serve cone photoreceptors therefore have to 
process more unesterified cholesterol, whilst rod RPE cells process more DHA (Curcio et al., 
2013).  
 
3.5.3 OCT of reticular pseudodrusen 
The advent of spectral domain OCT offered the opportunity to perform a more detailed in 
vivo study of the retinal layer affected by RPD. In 2010 three separate groups published their 
findings with Zweifel and colleagues being the first (Zweifel et al., 2010). They used a point-
to-point correlation between AF images and SD-OCT and for the first time in a living eye 
were able to correlate RPD with abnormal material lying internal to the RPE. They coined the 
term “subretinal drusenoid deposits”. A second group in Germany correlated their OCT 
findings with near infrared reflectance images, arriving at the same conclusion (Schmitz-
Valckenberg et al., 2010). The final report by Spaide and Curcio confirmed these findings and 
added histological evidence (Spaide and Curcio, 2010). 
Querques and colleagues were then able to use SD-OCT to propose a four stage classification 
for RPD, depending on the retinal layer affected by deposit (Querques et al., 2012a). Stage 1 
pseudodrusen were defined as granular material between the RPE and the inner 
segment/outer segment (IS/OS); stage 2 as mounds of material sufficient to alter the 
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contour of the IS/OS; stage 3 as thicker material adopting a conical appearance and breaking 
through the IS/OS; and stage 4 as fading of the material due to resorption and migration 
within the inner retinal layers. In the same work they were able to quantify the changes in 
stage over time, identifying that RPD progress though these stages. More recently, Suzuki et 
al. have described a complimentary approach, using multimodal imaging techniques to 
define three unique types of pseudodrusen according to their reflectance properties (Suzuki 
et al., 2014). Two of these (dot and ribbon) occur in the posterior retina with a third type 
(mid-peripheral) being found outside the arcades, although this type was seen in only 8/140 
eyes with RPD. The main SD-OCT feature differentiating these lesions is their B scan profile, 
peaked for dot lesions, broader mounds for ribbons and more rounded for the mid-
peripheral type (Suzuki et al., 2014). Overall a sensitivity of 94.6% has been reported for the 
use of SD-OCT for identifying all types of RPD, alongside a specificity of 98.4%, indicating the 
utility of this examination for detecting these deposits (Ueda-Arakawa et al., 2013). 
An interesting phenomenon observed in SD-OCT imaging of RPD are light “stripes” visible in 
the choroid under a subset of pseudodrusen.  These result from enhanced infrared light 
penetrating in certain regions. Loss of structures that absorb these wavelengths are thought 
to cause this appearance, and so this is likely to represent the impact of RPD on the RPE. As 
not all RPD are associated with light stripes this sign may signify progression to a stage of 
RPD that causes local RPE degeneration. This phenomenon appears to be independent of 
the size of RPD and is seen without manifest alteration to the RPE/BM line on SD-OCT 
(Meadway et al., 2014).  
Figure 4 shows the OCT (and infrared reflectance) appearance of RPD together with an age-
matched control subject for comparison. 
Figure 4. Appearance of reticular pseudodrusen (RPD) on OCT and infrared reflectance. A, 
Infrared reflectance and horizontal OCT scan through the fovea of an 81 year-old subject 
with a healthy macula. B, Corresponding images from an 87 year-old patient with both 
conventional sub-RPE drusen and RPD (clearly visible on the infrared reflectance image). C 
and D, images from the superior macula in both subjects. “Light stripes” in the choroid are 
also evident in the patient with RPD. 
OCT has also been useful in recording the associated choroidal changes of reduced choroidal 
thickness, macular choroidal volume and narrowing of the choroidal vessels. The exact 
relationship of these changes to RPD development is yet to be resolved (Ueda-Arakawa et 
al., 2014).   
 
3.5.4 Fundus autofluorescence of reticular pseudodrusen 
With the advance of AF imaging, reticular patterns of change were described, first by Lois et 
al. (Lois et al., 2002). In their report, however, they did not attribute these changes to RPD, 
but did comment that there was poor concordance with visible drusen. RPD visible on 
fundus photographs were then later correlated with the reticular pattern seen on FAF 
imaging (Smith et al., 2006). Using this technique, RPD are characterised by 
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hypofluorescence, in an interconnected network, matching the “reticular pattern of FAF” 
previously described by Lois et al (Lois et al., 2002). This contrasts with the moderately 
increased AF exhibited by foveal soft drusen and the variable degree of AF possessed by 
other typical drusen (Lois et al., 2002). A subretinal location is likely to block reflectivity from 
the RPE accounting for the characteristic dark appearance on AF imaging. The 
hypoautofluorescent nature of these lesions additionally suggests that they are not directly 
derived from photoreceptor outer segments as these would be highly autofluorescent due 
to abundant bisretinoid. Recently, Lee and Ham have identified a minority of RPD that 
display hyperautofluorescence, which suggests that these deposits additionally contain 
retinoid components either from the photoreceptor, or lipofuscin from the RPE (Lee and 
Ham, 2014). They conclude by suggesting that RPD may fall into at least two types, classical 
hypoautofluorescent RPD and a hyperautofluorescent variant (Lee and Ham, 2014).  
 
3.5.5 Fundus fluorescein angiography of reticular pseudodrusen 
In the original description of RPD, Mimoun et al. reported lesions that were hypofluorescent 
using FFA (Mimoun et al., 1990). Subsequently only subtle variation from this has been 
described, ranging from no demonstrable change to minimal hypofluorescence (Prenner et 
al., 2003). Others have suggested that there are visible choriocapillaris filling defects in the 
early phase of the angiogram (Smith et al., 2009). As RPD are found above the RPE this is 
likely to influence their angiographic phenotype. Whilst the lack of RPE filtering may be most 
important when imaging with other modalities, RPD occupy a site inside the blood-retina 
barrier, limiting their exposure to fluorescein, perhaps in part explaining their 
hypofluorescence. RPD are also hypofluorescent in the mid- to late-phase ICGA (Arnold et 
al., 1997). Smith et al. found a sensitivity of 100% for ICGA, whereas Ueda-Arakawa et al. 
suggested a lower figure of 73% (Smith et al., 2009; Ueda-Arakawa et al., 2013). These 
differences may reflect contrasting study design, as the former was a retrospective review 
that included ICGA data for 9 eyes whereas the latter prospectively examined 220 eyes. 
 
3.5.6 Multimodal confocal scanning laser ophthalmoscope imaging of reticular 
pseudodrusen 
Confocal scanning laser ophthalmoscopy (Macauley et al.) uses a focused laser beam, 
illuminating a small retinal area, which is then scanned across the retina to produce a full 
image. The reflected light is then captured through a small aperture (a confocal pinhole) 
which suppresses light reflected or scattered from outside of the focal plane, which would 
otherwise result in a blurred image. This results in a sharp, high contrast image of the object 
layer located at the focal plane. Comparing camera-based imaging systems with CSLO has 
shown that the camera produces lower quality images due to its inability to separate 
reflected and scattered light (Elsner AE, 1990). CSLO may be used with a range of excitation 
sources (infrared, near-infrared, blue, green) and also in conjunction with barrier filters, in 
order to acquire AF as well as reflectance images. Illuminating with longer wavelength light 
results in greater fundus reflectance and for near infrared (NIR) light, it is approximately 1 
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log unit higher than visible light, aiding imaging of deeper structures (Elsner AE, 1990). Fig. 
4D shows infrared reflectance imaging in RPD.  
 
Infrared (815nm) reflectance (IRR)  
Two groups, 4 years apart, have compared different techniques for diagnosing reticular 
lesions, and in both cases identified IRR as one of the most sensitive methods for detecting 
RPD (95% and 94.6%, respectively) (Smith et al., 2009; Ueda-Arakawa et al., 2013). Querques 
et al were also able to identify RPD better on IRR CSLO than blue light and camera based 
reflectance methods (Querques et al., 2012a). Additionally IRR is able to identify central 
macular lesions better than blue wavelength light, and this is thought to relate to the 
presence of luteal pigment that preferentially absorbs the shorter wavelength light (Smith et 
al., 2009). Suzuki et al. also found it easier to identify dot type RPD (that also tended to be 
more central) using IRR compared to colour fundus photography (Suzuki et al., 2014). 
 
Near infrared (790nm) reflectance (NIRR) 
Using near infrared CSLO RPD are characterised as groups of hyporeflectant lesions against a 
mild hyperreflectant background (Querques et al., 2012a). Less commonly, they may also be 
seen faintly at the fovea on AF and in near infrared light. A distinct, and frequently evident 
feature of RPD lesions is the so-called “target lesion”, as some lesions, there is a 
hyporeflective annulus and an isoreflective centre (Querques et al., 2012a). The authors 
attribute the target aspect to an interruption of the ellipsoid zone (EZ), which correlates to 
RPD stage 3 (Querques et al., 2012a). Adding a barrier filter to block pure reflectance allows 
NIR- FAF detection, although this is the least sensitive imaging modality due to the 
decreased contrast between the lesions and the background.  
 
Multicolour Reflectance (Blue, Green, Infrared) 
Recently, Alten et al. have used multispectral CSLO (infrared, green and blue) to detect RPD 
reporting detection rates comparable to the use of NIRR and short wavelength 
autofluorescence (Alten et al., 2014). However if the RPD contained a “target aspect” 
multicolour reflectance appeared to be the more sensitive modality, detecting RPD in an 
additional 23% of eyes where NIRR and short wavelength autofluorescence failed to identify 
the lesions (Alten et al., 2014).  
As RPD identification using a single-image modality is challenging, to enable an accurate 
diagnosis, we suggest that RPD detection should be performed with two or more image 
modalities (particularly OCT and infra red reflectance). 
 
3.6 Outer retinal corrugations, hyperreflective pyramidal structures and 
“ghost drusen” 
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In 2008 Fleckenstein and colleagues reported their SD-OCT findings in 81 eyes of 56 patients 
with geographic atrophy secondary to AMD (Fleckenstein et al., 2008). They divided the 
retina into atrophic, junctional and peri-lesional zones and reported “crownlike structures 
with debris” occurring within the atrophic site (Fleckenstein et al., 2008). These lesions were 
associated with increased AF. Subsequently Ooto et al reported their SD-OCT findings in a 
similar cohort, and describe a curvilinear, hyperreflective, density above the line 
representing BM and within atrophic retina on OCT (Ooto et al., 2014). Below this line was a 
relatively hyporeflective space. These findings were present both in eyes with advanced 
geographic atrophy and neovascular disease. The authors follow the clinical description with 
a detailed analysis of their histological findings, which revealed a rippled layer of basal 
laminar deposit, in an area of RPE atrophy, at the same level as the curvilinear line seen in 
the OCT images. They conclude by suggesting that BlamD may correspond to the “outer 
retinal corrugations” visible on OCT.  
Shortly after, in the same year, Bonnet et al described their own findings in patients with GA 
(Bonnet et al., 2014). These authors preferred to introduce the term “hyperreflective 
pyramidal structures” (HPS) to describe the same OCT feature that Ooto and colleagues had 
called outer retinal corrugations (Bonnet 2014). HPS appeared on IR image as a 
hyporeflective lesion surrounded by a hyperreflective halo (Bonnet et al., 2014). Using short 
wavelength autofluorescence, HPS were most commonly hypoautofluorescent, in 57 of 96 
cases (59%). Multicolor reflectance imaging identifies these structures as having a “peculiar 
green reflectivity” (Bonnet et al., 2014). Imaging with SD-OCT, HPS present a heterogeneous 
hyper-reflective internal boundary with a hyporeflective core. The same authors 
hypothesised that HPS may represent the end stage of soft drusen, with spontaneous 
drusen regression leaving only the “scaffold” which is visible on OCT. Due to the hollow 
appearance and pseudopyramidal structure the authors compare their likeness to a cartoon 
ghost, and as they are found in areas of “dead” RPE introduce the term “ghost drusen”. 
The lesions reported by Fleckenstein and Bonnet may actually represent different stages of 
the same process, the former retaining some autofluorescence associated with the debris 
contained within the internal hyperreflective boundary. If the lesions are internally 
hyporeflective, as in the studies of Ooto and Bonnet, then these structures are 
hypoautofluorescent. As they occur in regions of GA, where no RPE is expected, it has been 
suggested that the hyperrelective material is not derived from lipofuscin or retinoid 
components. Recent work however has questioned if regions of GA really represent cell 
deserts, as patchy preservation of both the RPE and neurosensory retina has been observed 
(Zanzottera et al., 2015). 
In addition to their presence in advanced AMD, we have identified the same lesions in 
patients with advanced Late-Onset Retinal Degeneration (L-ORD), and also in Sorsby Fundus 
Dystrophy (Figure 5). HPS appear to assume different conformations: “soft edged” individual 
pyramids in the mid-peripheral macula, peaked “invasive” pyramids at the fovea and 
coalescing pyramids in the far periphery. The highly reflective boundary of these structures 
may represent translocating mitochondria, as they move into the innermost retinal remnant 
of the photoreceptor, together with Muller cell gliosis. We have not observed HPS co-
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existing with outer retinal tubulations (ORT). As both lesions are found in regions of 
advanced outer retinal atrophy, HPS may represent an earlier form of ORT that still remain 
“attached” at their base. However, it remains possible that they represent alternative 
endpoints.  
Figure 5. Hyperreflective pyramidal structures (“ghost drusen”). A, Short wavelength AF 
image from the right eye of a 68 year-old male patient with genetically confirmed late-
onset retinal degeneration (L-ORD), showing marked RPE loss at the posterior pole. B, 
Infrared reflectance (left) and corresponding horizontal OCT line scan (right) through an 
area of geographic atrophy. C and D, Corresponding images from a patient with Sorsby 
Fundus Dystrophy (SFD). Hyperreflective pyramidal structures are visible on the OCT 
images. 
 
4. Eye disorders with drusen or drusen-like deposit (excluding AMD) 
In this section, we will describe eye conditions, other than age-related macular 
degeneration, in which drusen or drusen-like lesions may occur. Macular dystrophies can 
mimic a number of AMD features (recently reviewed by Saksens et al., 2014), but here the 
focus is particularly on those conditions yielding drusen-like lesions as part of their 
phenotype. In the first part (Section 4.1), we will discuss inherited conditions, beginning with 
inherited defects in the retinoid cycle, which can result in white dots. Some of these lesions 
can be localised to the subretinal space on OCT, and we will therefore refer to them 
collectively as subretinal drusenoid deposit SDD. In general, these conditions may also be 
associated with reduced autofluorescence signal (with the exception of ABCA4 retinopathy 
which exhibits a much higher signal). Subsequently, we discuss a range of other disorders 
associated with drusenoid lesions. These conditions are largely monogenic. In the next 
section (Section 4.2), we go on to discuss conditions whose inheritance has not yet been 
established that may result in whitish deposits.  
 
4.1 Inherited retinal conditions  
4.1.1 Genetic abnormalities of the retinoid cycle resulting in white dots 
Vertebrate phototransduction is initiated by a photochemical reaction. Here, 11-cis-retinal 
bound to its opsin undergoes isomerisation to all-trans-retinal producing conformational  
changes in the opsin (for a comprehensive review, see (Lamb, 2013). Restoration of a 
photosensitive visual pigment requires the regeneration of 11-cis-retinal from all-trans-
retinal via the retinoid cycle. In this section, instead of listing each genetic disorder 
separately, we will discuss important steps in this process, and highlight where dysfunction 
can be associated with drusenoid, yellow-white deposits. Figure 6 depicts schematically 
steps in the retinoid cycle. Table 3 list the relevant genetic disorders that can lead to white 
dots. 
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An acquired cause of reduced retinoid cycle activity, Vitamin A deficiency, can also result in 
white dots, and will be discussed in Section 5. 
 
Figure 6. Schematic representation of the retinoid cycle. Asterisks indicate particular 
proteins in which mutations in the coding genes can give rise to white dots. ABCA4 is 
shown here facilitating removal of all-trans-retinal from the outer segment disc lumen.  
 
Reduction of all-trans retinal to all-trans retinol takes place in photoreceptor outer 
segments; all other reactions, including isomerisation, occur within RPE. The all-trans 
retinylidene Schiff base hydrolyses and all-trans-retinal dissociates from the binding pocket 
of opsin. Removal of all-trans retinal from the discs, into the photoreceptor cytoplasm, may 
be facilitated by an ATP-binding cassette transporter (ABCR) (Beharry et al., 2004). 
Mutations of this protein, in particular subunit A4 (ABCA4), are known to cause an array of 
retinal diseases including macular, cone and cone-rod dystrophies (Allikmets et al., 1997). 
Typically, yellow-white deposit accumulates at the outer retina/RPE interface, classically 
described as pisciform flecks. These can be easily differentiated from drusen by their 
appearance on fundus photography and intense hyperautofluorescence on FAF imaging. The 
deposits are usually first identified in the first to third decades, and so are not mistaken for 
age-related drusen. Lastly their anatomical location within the retina can be variable, as the 
lesions evolve, and the deposits may even migrate into the outer nuclear layer (Voigt et al., 
2010). Occasionally, if examined in the earliest stages of disease, white dots, rather than 
flecks, may be observed in the central macula, prior to the atrophic changes (Figure 7).  
 
Figure 7. Fundus appearance of a patient with genetically proven biallelic mutations in 
ABCA4 (Stargardt macular dystrophy), aged 16 (left images), 21 (middle images) and 25 
years (right images). A-C, colour fundus photographs, with the macular region magnified in 
the middle panels (Amel et al.), and corresponding short wavelength autofluorescence 
images in the lower panels (G-I). The characteristic hyperautofluorescent flecks are 
evident in the later images, but white dots are also apparent, particularly in the earliest 
image. 
 
In the next step of the retinoid cycle, all-trans-retinal is reduced to all-trans-retinol by 
NADPH-dependent all-trans retinol dehydrogenase, a membrane-associated enzyme 
encoded by the gene RDH12 (Haeseleer et al., 1998). All-trans retinol then exits the 
photoreceptor and translocates to the RPE bound to interphotoreceptor retinoid binding 
protein (IRBP), and enters the RPE (Ala-Laurila et al., 2006; Bunt-Milam and Saari, 1983; 
Okajima et al., 1994; Wu et al., 2007).  
Once inside, all-trans retinol is transferred to the cellular retinoid binding protein (CRBP) and 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
37 
 
delivered to the first visual cycle enzyme in the RPE, lecithin retinol acyl transferase (LRAT) 
(Saari, 1982; Saari and Bredberg, 1989). LRAT links all-trans retinol to phosphatidyl choline in 
the RPE membrane, and in the process transfers an acyl group, generating all-trans retinyl 
esters. All-trans retinol from the systemic circulation also enters the visual cycle through the 
basal surface of RPE cells and is esterified here by LRAT. Homozygous frameshift mutations 
in LRAT associated with Leber Congenital Amaurosis (early-onset rod-cone dystrophy) can 
result in white dots (Littink et al., 2012).  
Retinyl esters generated by LRAT are the primary storage form of vitamin A in the eye. 
Impairment of vitamin A supply, either as a result of dietary deficiency, lack of a transporter 
protein (RBP4) or even perhaps limited diffusion across a thickened BM (such as in Sorsby 
macular dystrophy and pseudoxanthoma elasticum – see Section 5) can also result in white 
dots.  
The next step of the visual cycle involves two simultaneous processes, both performed by 
the enzyme RPE65: a trans/cis alkene bond isomerisation and an ester bond cleavage, 
generating 11-cis retinol (Deigner et al., 1989; Jin et al., 2005; Mata et al., 2004; Redmond et 
al., 1998). RPE65 is essential for the regeneration of 11-cis retinoid, and there is no 
isomerohydrolase activity in its absence (Redmond et al., 2005). RPE65 deficiency can also 
be associated with white dots (Weleber et al., 2011) in the form of SDD.  
11-cis retinol then binds cellular retinaldyhyde binding protein (CRALBP) (Saari et al., 2001). 
Mutations in the gene RLBP1 that encodes the protein CRALBP cause Bothnia dystrophy and 
Newfoundland rod-cone dystrophy, highly recognisable retinal phenotypes due the 
numerous white dots spread throughout the fundus (Burstedt and Golovleva, 2010; Eichers 
et al., 2002). Early in disease patients with Bothnia Dystrophy have changes similar to those 
with RDH5 retinopathy, however the former progress to significant chorioretinal atrophy 
(Figure 8) that may then be mistaken for Gyrate Atrophy. Colour fundus photography 
appears to show two types of deposit: peripheral white dots of varying sizes which are easily 
visible, and also barely visible macular changes (Fig. 8). These central lesions are visible on IR 
reflectance imaging (Fig. 8E,F), as they distort the outer retinal structure, particularly the 
ellipsoid zone, and are reminiscent of dot subretinal drusenoid deposit. In keeping with this, 
the lesions can evolve appearing to erode through the ellipsoid zone and towards the 
external limiting membrane.  
Figure 8. Retinal imaging in a 6 year old patient (A-F) and a 75 year old patient (G,H) with 
Bothnia Dystrophy. A-D, colour fundus images from the younger patient (A and B show 
widefield images; C and D show the posterior pole). E, Infrared reflectance image of right 
macula with OCT scan through the fovea. F, OCT and infrared reflectance image for the left 
eye. The OCT shows what appear to be subretinal drusenoid deposits. G,H, Wide-field 
fundus images from the older patient showing widespread chorioretinal atrophy.  
CRALBP delivers 11-cis retinol to 11-cis retinol dehydrogenase (11-cis RDH) for the final 
enzymatic step within the RPE. 11-cis RDH oxidizes 11-cis retinol to 11-cis retinal using NAD 
as a cofactor (Driessen et al., 1995; Simon et al., 1995). Mutations in RDH5, the gene 
encoding 11-cis RDH cause fundus albipunctatus (FA) another recognisable phenotype 
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(Figure 9). Similar to mutation of RLBP1, pathogenic variants in RDH5 appear to result in 
subretinal deposit deposition. Similar lesions appear on the OCT images presented by Pichi 
et al. (Pichi et al., 2013). In contrast to AMD related SDD, the subretinal deposits in FA start 
as a ring around the macula, leaving the central area unaffected, and spread towards the 
equator. The dots are white, or greyish white; distinct and individual, and mostly uniform in 
size. On FFA, most of these dots are not seen or they block fluorescence. The fundus shows 
low overall levels of autofluoresence, but when the gain is increased, some central deposits 
show higher than background levels of autofluorescence, suggesting that they contain some 
bisretinoid product, even if the absolute levels are low (Sergouniotis et al., 2011b). 
 
Figure 9. Images from a patient with fundus albipunctatus (RDH5-associated retinopathy). 
A and B, colour fundus images from right eye aged 7 (A) and 10 (B) years. The later image 
shows a few additional deposits. C and D, Infrared reflectance and OCT images from the 
right eye (aged 10): the deposits appear to be subretinal, but with some discontinuity in 
the ellipsoid layer seen also. E, Short wavelength autofluorescence image from the right 
eye (aged 11): a low overall autofluorescence is seen, but the deposits have higher levels 
of autofluorescence than the background and are visible when the gain is increased. 
 
11-cis retinal, again transported by IRBP, crosses the sub-retinal space and re-enters the 
photoreceptors (Ala-Laurila et al., 2006; Crouch et al., 1992; Wu et al., 2007). Once inside 
the outer segment it is transported back into the disc membrane, and the newly generated 
11-cis retinal can re-bind opsin - a functional visual pigment has been regenerated.  
 
Table 3. Visual cycle genes in which bi-allelic mutations may lead to white dots as part of 
the retinal phenotype. Function of the encoded protein is listed together with the disease 
entities, and phenotypic features. The white dots sometimes seen early in ABCA4-
associated retinopathy are seen at the macula, and are phenotypically different from 
those seen in the other conditions, in which the dots tend to spare the perifoveal area. 
RDH5-associated retinopathy is usually non-progressive. The full names of the genes are 
given in table 1. 
 
Gene Function Disease entities Retinal phenotypic features 
ABCA4 Binds both all-trans retinal and 
N-retinylidene-
phosphatidylethanolamine; 
Facilitates transport of all-trans 
retinal from outer segment discs 
and also may play a role in 
removal of excess accumulation 
Stargardt disease, 
fundus flavimaculatus, 
cone and cone-rod 
dystrophies 
Hyperautofluorescent retinal 
flecks; bull’s eye maculopathy; 
areas of atrophy; white dots may 
be seen in early disease. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
39 
 
of bisretinoid products 
LRAT Generates all-trans retinyl esters 
from all-trans retinol 
Leber congenital 
amaurosis, early onset 
severe rod-cone 
dystrophy 
White dots may be seen; 
progressive outer retinal atrophy  
RPE65 Generates 11-cis retinol from all-
trans retinyl esters 
Leber congenital 
amaurosis; early onset 
severe rod-cone 
dystrophy 
White dots may be seen; 
progressive outer retinal atrophy 
RLBP1 Encodes CRALBP which binds 11-
cis retinol and delivers it to RDH 
Bothnia dystrophy; 
Newfoundland Rod-
Cone Dystrophy; fundus 
albipunctatus 
Numerous white dots (similar to 
RDH5, but later progresses to 
extensive chorioretinal atrophy) 
RDH5 Oxidises 11-cis retinol to 11-cis 
retinal within the RPE. 
Fundus albipunctatus Numerous white dots (generally 
non-progressive) 
 
Cone photoreceptors are believed to also access an alternative visual cycle via Muller cells 
that can bypass the RPE (Mata et al., 2002). Here, all-trans retinol generated in 
photoreceptors is transported to Müller cells and isomerized to 11-cis retinol by an 
unidentified isomerase. 11-cis retinol from Müller cells then enters the inner segments of 
cone photoreceptors and is oxidised to 11-cis retinal for visual pigment formation (Bunt-
Milam and Saari, 1983; Saari et al., 1985). A functional relationship between IRBP, Müller 
cells, and cone inner segments in a cone-specific pathway is yet to be proven however, but 
this hypothesis does perhaps explain the relative foveal sparing of RDH5, RLBP1 and RPE65 
related retinopathies, at least early on in the disease course. 
 
4.1.2 Familial benign fleck retinopathy (PLA2G5) 
An identical appearance to the retinopathies associated with mutation of RDH5 and RLBP1 
can also be observed with bi-allelic mutation of PLA2G5. Although there is phenotypic 
overlap the latter patients do not suffer from any loss of function (Sergouniotis et al., 
2011a). Figure 10 shows the fundus appearance. In contrast to defects in the retinoid cycle, 
there is no low overall autofluorescence, but the dots are hyperautofluorescent. The OCT 
images resemble subretinal drusenoid deposits, though some disturbance of the RPE may be 
evident.   
Figure 10. Retinal images of a 39 year-old female with bi-allelic mutation in PLA2G5. A,B,C 
Images from the right eye. D,E,F, Images from left eye. A and D are colour fundus 
photographs showing numerous white dots. B and E are short wavelength AF images 
showing that the lesions are hyperautofluorescent. C and F show infrared reflectance and 
OCT images. 
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4.1.3 Dominant drusen (EFEMP1) 
Patients with dominantly inherited drusen (DD) were originally described as Doyne 
honeycomb retinal dystrophy in the UK and as Malattia Leventinese in Switzerland (Doyne, 
1899; Vogt, 1925). It was later realised that both conditions were the same, as a single 
missense mutation (p.Arg345Trp) in EFEMP1 is responsible (Stone et al., 1999). Mutation of 
Fibulin-3, the protein encoded by EFEMP1, has been shown to result in focal thickening of 
BM, evident at the macula and sparing the peripheral basement membrane (Marmorstein 
2002, Sohn 2015). Characteristic signs are early-onset drusen at the posterior pole (Figure 
11) and in the peripapillary area, with a radial distribution in some cases; although drusen 
abutting the optic nerve head has been shown to be most suggestive of DD (Michaelides et 
al., 2006). With age the drusen become confluent and BM becomes increasingly separated 
from the RPE. Dysfunction is usually confined to the macula, and consequently the ffERG is 
usually normal (Michaelides et al., 2006). Three groups have looked in detail at the clinical 
phenotype associated with mutation of EFEMP1 (Michaelides et al., 2006; Querques et al., 
2013; Zweifel et al., 2012). In the first two studies, a radial pattern was not always seen 
(Michaelides et al., 2006; Zweifel et al., 2012). Most drusen exhibited very early 
hyperfluorescence, identical to that seen with cuticular drusen. SD-OCT imaging suggested 
the presence of two different phenotypes – a saw-tooth like elevation of the RPE, consistent 
with cuticular drusen, which may become confluent with time, and deposit lying anterior to 
the RPE, typical of SDD. The NI-R and AF signatures were however not characteristic of RPD. 
The third report by Querques and colleagues concurred with the identification of cuticular 
drusen but suggested the larger drusen shared more similarities with conventional drusen 
rather than SDD (Querques et al., 2013). These conclusions have been extended by the 
recent work demonstrating that although the drusen of DD share many similarities with 
those seen in AMD, morphological differences do exist (Sohn et al., 2015). DD is 
characterised by a major disruption to the ECM, consequently these drusen, unlike those of 
AMD, contain elevated levels collagen type IV but reduced levels of TIMP3 (Sohn et al., 
2015). DD also display an unusual onion skin–like lamination separating the eosinophilic and 
sudanophilic layers, which is thought to relate to ECM molecules aggregating with fixed 
periodicity. These drusen also display high immunoreactivity to antibodies directed against 
the membrane attack complex (C5b-9) component of complement, a feature shared with 
hard but not soft drusen (Sohn et al., 2015).  
As seen with substantial coalescing cuticular drusen, subretinal fluid may accumulate in DD, 
even in the absence of identifiable neovascular disease. Such cases may be observed, as the 
fluid tends not to increase significantly, nor does haemorrhagic transformation tend to occur 
in our experience. Additionally, when treated with intravitreal anti-VEGF therapy, the 
subretinal fluid often persists. Macular atrophy is seen as a late event. 
Figure 11. Examples of phenotypes seen in EFEMP1 disease (“dominant drusen”). The 
panels show (from left to right) colour fundus photographs, short wavelength 
autofluorescence, infrared reflectance and horizontal OCT scans, all from the right eye. 
Upper panels (A-C) are from a 21 year old patient with early disease. The middle and lower 
panels are from a sister and brother showing how expression can be variable in the same 
family. The middle panels (Amel et al.) are from a 62 year old female with severe disease. 
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The lower panels (G-I) are from her brother (aged 59) who has mild disease. The 
commonly described appearance of radially distributed drusen is not evident in these 
cases, but drusen abutting the optic nerve head are visible (middle and lower panels). 
 
4.1.4 Sorsby fundus dystrophy (TIMP3) 
Sorsby fundus dystrophy (SFD) is a rare autosomal dominantly inherited retinal dystrophy 
producing symptoms after the third decade of life (Sorsby, 1949). The most common 
presentation is due to central visual loss but in almost all cases this is preceded by a period 
of disturbance of dark adaptation and nyctalopia (Steinmetz et al., 1992). SFD is now known 
to result from mutation of a single gene - the tissue inhibitor of metalloprotease 3 (TIMP3) 
with causative genetic variants being found almost exclusively in exon 5 or the preceding 
exon-intron boundary (Weber et al., 1994). The mutated TIMP3 protein is thought to form 
dimers, almost always the result of a gain or loss of a cysteine residue. These dimers are 
more resistant to normal catabolic cellular metabolism and so accumulate in BM. 
Histologically these changes result in widespread thickening of BM (Capon et al., 1989). In 
some cases this may be visible on imaging with SD-OCT. A major feature of early SFD is the 
presence of yellow drusenoid deposit, that later progress to atrophy. A major contributor to 
the yellow deposits are SDD (reticular pseudodrusen) (Gliem et al., 2015b), as shown in Fig. 
12. Perhaps as a consequence of premature BM thickening, the SDD of SFD occur at an 
earlier age of onset compared to those seen in AMD. In more severe or advanced disease, as 
in AMD, marked atrophy may ensue with hyperreflective pyramidal structures seen on OCT 
(Fig. 5).  
Figure 12. Retinal imaging from two patients with early or mild SFD. A, Colour fundus 
photograph from the right eye of a 41 year-old female patient. B, Colour fundus 
photograph from the right eye of a 49 year-old female patient. C and D, “Multicolor” and 
short-wavelength AF imaging with CSLO of the patient in A. E and F, corresponding images 
from patient in B. G and H, Infrared reflectance and OCT imaging from both patients. The 
lesions are more possibly more easily defined on the CSLO images (Gauter-Fleckenstein et 
al.) than on the colour fundus photographs (A,B), and OCT imaging shows the majority to 
be SDD. An SFD patient with more advanced disease is shown in Figure 5. 
 
4.1.5 Late-onset retinal degeneration (C1QTNF5) 
Late-onset retinal degeneration (L-ORD) is an autosomal dominantly inherited disorder, 
characterized by loss of rod function starting in the fifth to sixth decade. Central visual loss 
then ensues as a result of severe chorioretinal atrophy or neovascularization. All cases to 
date harbour the p.Arg163Ser mutation in C1QTNF5 (Hayward et al., 2003). Histopathology 
of a donor eye revealed a thick layer of extracellular deposits between the RPE and BM 
underlying marked areas of photoreceptor loss (Kuntz et al., 1996; Milam et al., 2000). The 
deposit is estimated to be approximately 50 μm, containing a mixture of substances rich in 
lipids, collagen mucopolysaccharide, elastin, Muller cell processes and rhodopsin-positive 
neurons extending from the central retina to the ora serrata (Kuntz et al., 1996; Milam et al., 
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2000; Shu et al., 2006). Similar to SFD, early L-ORD is characterized by nyctalopia and the 
presence of SDD (Figure 13). Later in disease, ghost drusen dominate (HPS) as shown 
previously in Figure 5.  
Figure 13. Images from a 60 year-old female with late-onset retinal degeneration. A, 
colour fundus photograph from the right eye. B, Infrared reflectance and horizontal foveal 
OCT scan. C, Short wavelength autofluorescence imaging. D, Slit lamp photograph of 
anterior segment showing anteriorly placed zonular insertions, which are seen in this 
condition. Images from a patient with more advanced disease are shown in Fig. 5. 
 
4.1.6 IMPG1 and IMPG2 carriers 
IMPG1 (interphotoreceptor matrix proteoglycan 1) encodes SPACR, a 150kDa sialoprotein 
associated with rod and cone photoreceptors. It is a major component of the 
interphotoreceptor matrix, the site where rods and cones interact with the RPE (Felbor et 
al., 1998; Kuehn and Hageman, 1999). SPACR is highly homologous to SPACRCAN 
(sialoprotein associated with photoreceptor cone and rod proteoglycans), a 200 kDa protein 
encoded by IMPG2 (interphotoreceptor matrix proteoglycan 2) and also found in the 
interphotoreceptor matrix (Acharya et al., 2000). Mutations in IMPG1 have been associated 
with both dominant and recessive forms of atypical vitelliform macular dystrophy (VMD) 
(Manes et al., 2013). In one family carriers of heterozygous mutations that result in recessive 
VMD showed an early onset drusen phenotype (family NA186) (Manes et al., 2013). 
Heterozygous IMPG2 mutations have also been reported to cause atypical vitelliform 
macular dystrophy whilst bi-allelic mutations cause RP, often with early macular 
involvement (Bandah-Rozenfeld et al., 2010). We have also recently seen the early onset 
drusen phenotype in a carrier of an IMPG2 mutation Figure 14); it is possible that this may 
be a feature of the carrier status for specific IMPG1/2 variants.  
Figure 14. Fundus images from patients with IMPG2 mutations. A, Wide-field colour 
fundus photograph of the right eye of a 19 year-old male with retinitis pigmentosa found 
to have bi-allelic mutations in IMPG2. B-D, images from the right eye of the patient’s 
mother (aged 39). B, Colour fundus photograph showing subtle drusen-like lesions around 
the fovea and superotemporally. C, Short-wavelength autofluorescence image showing 
hyper-autofluorescence of the lesions. D, Infrared reflectance image with horizontal foveal 
OCT scan. 
 
4.1.7 PRPH2–associated retinopathy 
Mutations in PRPH2 (Peripherin 2) are associated with a range of fundus phenotypes 
including those limited to the macula (adult vitelliform, butterfly pattern dystrophy, central 
areolar choroidal dystrophy), as well as those with more widespread changes associated 
with rod-cone, cone or cone-rod dystrophies. The latter may take the form of a classical 
retinitis pigmentosa phenotype, or appear similar to the flecked retina associated with 
mutation of ABCA4. Whilst these yellow outer retinal deposits are subretinal rather than 
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subRPE in location, using colour fundus imaging alone may lead to these deposits being 
mistaken for drusen. This may be especially the case for families where there is non-
penetrance, or at least variable expression of the fundus changes, as a history of dominant 
disease, or premature sight loss may not be elicited. This is particularly prevalent with the 
p.R172W mutation. For a comprehensive review of the phenotypic spectrum of PRPH2-
associated retinopathy see (Boon, 2014).  
 
4.1.8 CDHR1 retinopathy 
CDHR1 (cadherin 1) encodes the photoreceptor cadherin, a structural, transmembrane 
protein localized to the base of rod and cone outer segments that appears to be involved in 
maintaining their structure (Rattner et al., 2001). A range of fundus phenotypes have been 
reported with bi-allelic mutation of CDHR1 including irregular pigmentary changes, bulls-eye 
maculopathy, macular sheen, RPE migration into the retina, and outer retinal atrophy (Ba-
Abbad et al., 2013; Cohen et al., 2012; Duncan et al., 2012). We have recently examined a 43 
year old lady with early onset drusenoid deposit, where molecular genetic testing has 
identified recessive mutations in CDHR1. Figure 15 shows the retinal imaging findings in this 
patient. 
Figure 15. Images from the right eye of a patient with bi-allelic mutations in CDHR1. A, 
Colour fundus photograph shows a bulls-eye maculopathy appearance, with fine yellow 
dots at the periphery of the lesion. B, Short wavelength autofluorescence shows speckled 
hyperautofluorescent foci throughout the lesion. C, Infrared reflectance with a horizontal 
OCT scan showing, in addition to outer retinal/RPE atrophy, fine hyperreflective foci at the 
level of the photoreceptor outer segments. 
 
4.1.9 North Carolina Macular Dystrophy and NCMD-Like Disorders 
North Carolina Macular Dystrophy (NCMD, MCDR1) is an autosomal dominant congenital 
maculopathy first described as hereditary macular degeneration and aminoaciduria by 
Lefler, Wadworth, and Sidbury (Lefler, 1971). The origins have been traced to two Irish 
brothers who settled in North Carolina in the 1830s and the original North Carolina pedigree 
now consists of over 5,000 individuals (Small 1992). It has also been found in other 
unrelated individuals around the globe. Linkage studies have mapped MCDR1 to a locus on 
chromosome 6q16 which has latterly been refined to a 1.8 mb region (Yang et al., 2008). Just 
this year, Small and colleagues applied whole genome sequencing techniques to identify 
variants which segregate with the disease (Small et al., 2015). Bioinformatic filtering 
followed by segregation and gene expression studies have now implicated PRDM13 as the 
gene underlying the MCDR1 locus, a transcription factor now understood to be critical for 
macular development. 
The disease is characterized by symmetric, small, yellow, well defined drusen-like deposits 
confined to the foveal region with minimal impact on visual acuity (Grade 1); confluent 
yellow flecks with intermediate visual impairment (Grade 2); or a macular coloboma 
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surrounded by chorioretinal atrophy and pigmentation associated with moderate to severe 
visual impairment (Grade 3) (Small, 1989). These changes are either congenital, or appear in 
early infancy. Lesions are typically non-progressive however occasionally choroidal 
neovascularization occurs, resulting in anatomical remodeling and late vision loss (Small, 
1991). Peripheral changes have also been described with linear drusen accumulating 
(Pauleikhoff 1997; Reichel, 1998, Pichi, 2013). Functional testing usually establishes that 
disease is confined to the central macula however. Grade 1 lesions may not be easily 
identifiable by SD-OCT. They are usually hyperautofluorescent on FAF imaging and easily 
visible with this modality, suggesting that they may contain significant amounts of 
bisretinoid or another fluorophore (given that, with such early onset lesions, it may be 
unlikely that significant bisretinoid will have accumulated).  
NCMD-like phenotypes mapping to genetic loci other than MCDR1 have also been described 
(MCDR3, MCDR4 and Sorsby Syndrome), for a recent review see (Michaelides et al., 2012). 
Affected individuals with both MCDR3 and MCDR4 can present with fine drusen-like 
deposits. MCDR3 may potentially be differentiated from NCMD by progressive drusen 
accumulation (Michaelides et al., 2003), whilst all affected family members of the sole 
MCDR4 pedigree also reported progressive sensorineural hearing loss (Francis et al., 2003).  
 
Figure 16. Images from a mother and son affected by North Carolina Macular Dystrophy. 
Upper panels show colour fundus photographs; lower panels show short wavelength AF 
images. A,C, Images from 16 year-old male with grade 1 NCMD. B,D, Images from 42 year-
old female with grade 3 disease. 
 
4.2 Eye disorders with undefined inheritance 
4.2.1 Gass’ grouped albinotic spots; Flecked Retina of Kandori 
Kandori described 4 cases from Japan with an unusual retinal appearance but good visual 
function (Kandori, 1959; Kandori et al., 1966; Kandori et al., 1972). The characteristic 
changes were large, irregular but sharply defined yellow patches in mid-peripheral retina 
and sparing the macula. These findings were not associated with electrophysiological 
abnormality. A similar case has been also reported by Fried et al. with additional signs of 
ectodermal dysplasia (Fried, 1972). No molecular genetic investigations have been 
performed in any of the reported families.  
Gass suggested that these lesions are identical to those seen in another condition, that he 
has termed congenital, grouped albinotic spots of the RPE (Gass, 1977). These lesions may 
be similarly numerous, although most commonly are much smaller in size than the cases of 
flecked retina reported above. A single case of familial disease exists, with the mother and 
three siblings from a Brazilian family of Italian heritage all affected (Arana et al., 2010). Gass 
proposed that this phenotype results from deposition of white material within the RPE, 
although no histological analysis has been performed. Window defects are observed over 
the white lesions during FFA. Kandori’s original and subsequent descriptions included cases 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
45 
 
also with night blindness and more widespread lesions, so it is possible that some of these 
may now be classified as fundus albipunctatus or the benign fleck retinopathy associated 
with PLA2G5. 
Figure 17 shows some examples of grouped albinotic spots. The lesions are not visible on 
OCT. They are seen as high intensity lesions on short wavelength AF imaging, suggesting that 
they do not simply represent depigmented RPE cells, but additional hyperautofluorescent 
material. The radial pattern is consistent with RPE migration during development. 
Interestingly, the third case shown in the lower panels of Figure 17 (albinotic spots confined 
to the superior or superonasal mid-periphery) does not exhibit hyper-autofluorescence. The 
AF image in this case (Fig. 17H) was obtained with the wide-field Optos system, as opposed 
to the CSLO-acquired AF images in (panels B and E). The difference might reflect a real 
difference in the properties of the deposits in the different cases or might be due to the 
different methods of image acquisition. The fundus appearance of the patient shown in the 
upper panels of Fig. 17 was stable over the course of 3 years, suggesting that these spots do 
not change over time. 
Figure 17. Images from patients with albinotic spots. A-C, 9 year-old girl; D-F, 25 year-old 
female; G,H, 11 year-old male). Images are colour fundus photographs (A,D,E), short 
wavelength autofluorescence (B,D,G) and infrared reflectance with horizontal OCT scans 
(C,F).  
 
4.2.2 Large colloid drusen  
Large Colloid Drusen (LCD) are large (200-300 μm), bilateral, and yellowish lesions located in 
the macula and/or peripheral retina (Figure 18), and have been described relatively recently 
as a new type of early-onset drusen (Guigui et al., 2011). They lie external to RPE, in 
common with conventional drusen. With short wavelength (488nm) autofluorescence they 
show variable, mild hyperautofluorescence, most commonly surrounded by a halo of 
hypoautofluorescence. In the late phase of ICGA, their core is hypofluorescent surrounded 
by a hyperfluorescent ring; Guigui and colleagues have referred to this as the “doughnut 
effect”. When investigated with FFA the doughnut occurs in the early phase, with late 
central hyperfluorescence. The bright surrounding halo is also present even without dye 
imaging using near infrared reflectance (Guigui et al., 2011). SD-OCT imaging suggests that 
the smallest LCD have no effect on the ellipsoid zone, and this is confirmed when the 
photoreceptor mosaic is imaged using adaptive optics SLO (AO-SLO) (Querques et al., 
2012b). Larger LCD erode into the photoreceptors (Querques et al., 2012b). Generally 
speaking however LCD are associated with minimal functional deficits (Guigui et al., 2011).  
Very recently there has been a single case report of LCD co-occurring with posterior 
polymorphous corneal dystrophy (PPCD), a presumed collagenopathy limited to Descemet’s 
membrane (DM) (Del Turco et al., 2015). As both DM and BM are collagen rich matrices this 
may suggest a common pathogenetic mechanism. Other associations are yet to be 
established. 
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Table 4. Features of large colloid drusen on retinal imaging. 
Colour fundus photography  (CFP) Large (200-300 μm) yellowish lesions, most common in the 
temporal macula initially but can be more widespread. 
Short wavelength auto-
fluorescence 
Variable, mild hyperautofluorescence, surrounded by a halo 
of reduced AF. 
OCT Sub-RPE deposits. Larger lesions may erode into the 
photoreceptors. The core tends to exhibit lower reflectivity 
than other drusen and in some cases can appear optically 
empty. 
Fundus fluorescein angiography Early central hypofluorescence with late hyperfluorescence. 
Indocyanine green angiography In the late phase, a hypofluorescent central core surrounded 
by a hyperfluorescent ring (the “doughnut” effect). 
 
Figure 18. Retinal imaging of a 19 year-old female with large colloid drusen. A and B, 
Colour fundus photographs from right and left eye respectively. C and D, Short wavelength 
AF images. E and F, Infrared reflectance and horizontal OCT scans from right and left eye 
respectively. 
 
4.2.3 Early onset drusen otherwise unclassified 
A large number of patients exist with early onset drusen that do not easily fit into any of the 
above diagnostic categories, differing either by phenotype or genotype. In almost all cases 
there is no manifest systemic disease and the patients’ history does not suggest an acquired 
cause. The symmetry and premature onset however hint at a genetic aetiology (Figure 19 
shows an example), although to date this hypothesis remains largely untested. These 
patients should not be considered a uniform cohort, rather they are most likely to represent 
a collection of unique groups, each with their own combination of risk factors that happen 
to share a final common pathway. Within this group certain patterns may be recognised, 
depending upon the site affected (macula only or more widespread), natural history (static 
or progressive) and degree of dysfunction. It is likely that future genetic, proteomic and 
metabolomics studies will be useful in sub-classifying these patients.  
Fig 19. Retinal images from a 41 year-old female with bilateral drusen. This patient 
underwent testing for mutations in the known genes underlying retinal or macular 
dystrophies with a negative result. The symmetry suggests a genetic aetiology. A, Colour 
fundus photographs (from a wide-field imaging system). B, Horizontal enhanced depth 
OCT image through the fovea of the right eye with corresponding infrared reflectance 
image. C, Short wavelength AF images. D, OCT and infrared images from the left eye.  
 
5. Disorders with systemic features 
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In this section we discuss disorders with systemic features, beginning with renal disease 
(Section 5.1) and then a number of other systemic conditions that may be associated with 
drusenoid lesions. 
 
5.1 Renal disease 
There are a number of diseases that may affect the eye and kidney. This is not confined to 
common diseases affecting the microvasculature in both organs, such as diabetes and 
hypertension, but also a number of more rare inherited diseases. Previous authors (including 
Savige et al., 2011) have pointed out the existence of shared developmental pathways for 
the eye and kidney, the importance of ciliary function in both podocytes and the 
photoreceptors, and similarities between the choriocapillaris and the fenestrated capillaries 
of the glomerulus. Drusen or drusen-like deposits may be seen in a few renal diseases. We 
will discuss membranoproliferative glomerulonephritis, which, like AMD, has an association 
with complement factor H variants. We will also discuss Alport syndrome, caused by 
abnormalities in Type IV collagen, in which white-yellow retinal lesions may be apparent. 
 
5.1.1 Type II membranoproliferative glomerulonephritis, dense deposit disease 
and C3 glomerulopathy. 
The initial classifications of membranoprofliferative glomerulonephritis (MPGN) were based 
on morphological characteristics, either with electron microscopy (defining dense deposit 
disease) or light microscopy (identifying mesangioprofliferative, membranoproliferative, and 
cresentic patterns). Recently this has been updated, with immunofluorescence techniques 
now being preferred to differentiate between disease processes. Accordingly, “C3 
glomerulopathy” (C3G) has been introduced to describe nephropathy associated with 
isolated deposits of C3, a hallmark of dysregulation in the alternative pathway of 
complement (Fakhouri et al., 2010). Included within this group are “C3 glomerulonephritis” 
(C3GN) (including some forms of MPGN 1 and 3) and dense deposit disease (MPGN2) 
(Servais et al., 2007). Other types of MPGN (the remaining forms of type 1 and type 3) result 
from mixed deposits of immunoglobulin and complement and are therefore not considered 
part of C3G. 
C3G is an inflammatory disease affecting the glomerulus of the kidney, in particular the 
capillary tuft, glomerular basement membrane and glomerular epithelium. As this site 
shares significant homology with the choriocapillaris, BM and RPE interface, these ocular 
structures may also be expected to show signs of damage in C3G. Whilst MPGN is associated 
with a range of other disorders, both autoimmune (SLE), chronic inflammatory conditions 
(hepatitis B and C) and immunoglobulinaemias to name a few, C3G is specifically associated 
with those relating to dysregulation in the alternative complement pathway. Many of the 
references below relate to historical descriptions reporting retinal phenotypes observed in 
patients with renal disease and so we refer to the nephropathy as the authors have. For 
clarity MPGN2, synonymous with DDD, is part of C3G. Similarly subgroups of MPGN type 1 
and 3 that are characterised by C3 deposition are included as C3G, in the sub-group C3GN, 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
48 
 
for review see (D'Agati and Bomback, 2012).  
In 1989, Duvall-Young and colleagues working in the Renal Unit at Manchester Royal 
Infirmary described the presence of drusen-like retinal deposits in patients with biopsy 
proven MPGN2 (Duvall-Young et al., 1989). Subsequently Mullins and associates, were able 
to examine eyes obtained from two human donors with MPGN2 (Mullins et al., 2001).  
Histologically these deposits exhibit sudanophilia, bind filipin, react with antibodies directed 
against vitronectin, complement C5 and C5b-9 complexes, TIMP-3 and amyloid P 
component, all hallmarks of AMD associated drusen. They concluded that the ultrastructural 
characteristics of these deposits were also identical with those of AMD associated Drusen 
(Mullins et al., 2001). Cuticular drusen were then identified as the major druse subtype, and 
are present in nearly 80% of dense deposit disease patients (McAvoy and Silvestri, 2005). 
Their widespread presence, at a young age, and in association with renal dysfunction may be 
considered pathognomonic of MPGN. 
Individuals with MPGN2 develop drusen from their second decade. Their distribution is 
variable and as in AMD in the early stages, is not associated with ocular morbidity (Colville et 
al., 2003; Duvall-Young et al., 1989). With time retinal dysfunction may develop, detectable 
even when the patient is asymptomatic (Colville et al., 2003; D'Souza Y et al., 2009; O'Brien 
et al., 1993). Further progression can be associated with choroidal neovascularisation and 
serous macular detachment, although how frequently this occurs and whether it is 
complicated by the necessary pharmacotherapy is not known (Colville et al., 2003). In 
contrast D’Souza and colleagues, reporting on the 10 year follow up of the original cohort 
described by Duvall-Young et al., did not find any evidence for a progressive retinopathy in 
the four surviving patients (no atrophy or CNVM) (D'Souza et al., 2008). Although limited by 
the small sample size, this group accurately characterised the clinical characteristics of the 
drusen in MPGN2. They found numerous (>20) deposits, with a variety of small (hard) and 
large (soft) drusen, even outside the arcades and small drusen that fluoresced greatly on 
angiography (cuticular drusen). Although we may not be able to use clinical signs to 
differentiate drusen associated with MPGN2 from those seen in AMD, they occur a 
significantly younger age (20s versus 60s) and are associated with renal dysfunction. Similar 
drusen have also been reported in MPGN1 (n=1) and MPGN3 (n=2) (Dalvin et al., 2015; Han 
and Sievers, 2009), perhaps unsurprising as we now recognise that isolated complement 
dysregulation is a defining feature for a subgroup of MPGN1 and 3.  
Figure 20. Retinal images from a 21 year-old female with histologically confirmed MPGN 
type 2. A, Colour fundus photographs. B, Horizontal OCT image through the fovea of the 
right eye with corresponding infrared reflectance image. C, Short wavelength AF images. 
D, OCT and infrared images from the left eye. The drusen-like lesions are visible on colour, 
AF and infrared imaging, but not easily discernible on OCT. 
 
5.1.2 Alport syndrome 
Alport syndrome is an important cause of inherited kidney disease and of early onset renal 
failure. It results from mutations in genes coding for type IV collagen α3α4α5, which is found 
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in a number of basement membranes including the lens capsule, the internal limiting 
membrane and BM, the glomerular basement membrane and the cochlea. Over 80% of 
Alport syndrome is X-linked, resulting from mutations in COL4A5. Autosomal inheritance 
syndrome results from mutations in COL4A3 or COL4A4, and the majority of this is 
autosomal recessive Alport syndrome. Extra-renal manifestations include deafness and 
ocular abnormalities. The latter include anterior lenticonus (which is pathognomonic, but 
present in a minority) and retinal abnormalities, which may aid diagnosis (Savige and 
Colville, 2009). Dots and flecks may be seen in the macula, with the flecks sometimes 
outlining a macular “lozenge”. The macular flecks appear to be related to hyper-reflectivity 
of the ILM on OCT imaging, and the macular “lozenge” appears to be related to temporal 
macular thinning (Savige et al., 2010). Mid-peripheral retinal flecks are also commonly 
observed, and at least in some patients, these have the appearance of mid-peripheral 
drusen.  
Figure 21 shows the fundus appearance of patients with X-linked and autosomal recessive 
Alport syndrome. The temporal macular thinning is evident (and extends nasal to the 
foveola also), and appears to be characteristic. We have seen a similar appearance only in 
some patients with sickle cell retinopathy, but the appearance in those patients is not 
usually so symmetrical. The macular white-yellow lesions appear to relate to 
hyperreflectivity of the ILM rather than drusen or drusenoid deposits. However, the mid-
peripheral lesions might be drusenoid though are too peripheral to easily capture with OCT. 
 
Figure 21. Retinal imaging from patients with X-linked Alport syndrome (A-C) and 
autosomal recessive Alport syndrome (Amel et al.). A, Horizontal OCT line scan through 
the fovea of a male patient with X-linked Alport syndrome, showing inner retinal thinning 
largely temporal to the foveola and hyper-reflectivity of the ILM. B, Colour fundus 
photograph from the left eye showing the dot/fleck maculopathy and the macular 
“lozenge” appearance. C, OCT from the left eye (corresponding to the green arrow in B) 
showing that the white yellow lesions appear to correspond to the hyper-reflective ILM 
rather than any drusenoid deposits. D, Montage of colour fundus photographs from a 
male patient with autosomal recessive Alport syndrome showing minimal macular dots, 
but mid-peripheral changes that could be drusenoid. E, F, infrared reflectance and OCT 
images from the right and left eye of the patient depicted in D. Temporal macular thinning 
is again seen together with a hyper-reflective ILM. 
 
5.2 Other diseases with systemic manifestations 
 
5.2.1 Vitamin A deficiency 
Dietary deficiency, malabsorption syndromes and self-inflicted vitamin A deficiency have all 
been described in association with retinal changes (Fell, 1969; Fuchs, 1928, 1959; Uyemura, 
1928). Yellow-white dots in the outer retina or RPE are seen, and SDD are evident on OCT. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
50 
 
The yellow dots have been reported to reduce in number with treatment. The SDD changes 
over time have been less well documented. As might be expected from a condition in which 
retinoid delivery is reduced, the appearance is similar to that seen in disorders of retinoid 
cycle (Section 4.1.1), and symptoms include nyctalopia. Full-field electroretinography is 
abnormal, with reduced rod-driven responses, though cone system function may be 
relatively preserved.  
Other ocular signs include conjunctival xerosis and Bitot’s spots and corneal xerosis 
(Venkatswamy, 1967). Systemic signs include angular stomatitis and dry, thickened skin. 
Figure 22 shows images from a patient with Vitamin A deficiency due to advanced liver 
disease (Vitamin A replacement in this situation is complicated due to hepatoxiocity). White 
dots are apparent on colour fundus photography, and CSLO imaging shows multiple small 
discrete entities, shown to be SDD on OCT.  
Figure 22. Retinal imaging from a patient with vitamin A deficiency due to liver disease. A, 
Colour fundus photograph showing white dots. B, “Multicolour” CSLO imaging showing 
small discrete deposits. C, Short-wavelength AF imaging showing hypo-autofluorescent 
spots. D, Infrared reflectance imaging and OCT scan showing that the lesions are 
consistent with subretinal drusenoid deposits. E-F, Corresponding images from the left eye 
of the same patient. 
 
5.2.2 Pseudoxanthoma elasticum 
Pseudoxanthoma elasticum (PXE) is a systemic inherited disorder of calcium metabolism 
resulting from mutation of ABCC6 (Bergen et al., 2000; Le Saux et al., 2000; Ringpfeil et al., 
2000). ABCC6 is a transporter protein present in hepatocytes, when mutated there is a 
reduced ability to carry its substrate pyrophosphate (PPi), resulting in low serum PPi. This 
facilitates ectopic calcification, which preferentially occurs in elastic lamina of the eye and 
systemic arterial vasculature. Retinal features include angioid streaks and a “peau d’orange” 
appearance of areas of retina (a mottled or stippled pattern of yellowish lesions, which may 
be due to focal calcification of BM). This term was introduced by Smith and coworkers 
(Smith et al., 1964), and may be the same as entities previously described by Bischler 
(Bischler, 1955) and Shimuzu (Shimuzu, 1961).  
SDD have also recently been reported to occur as a consequence of BM calcification in PXE 
(Gliem et al., 2015a). In addition, we have recently observed retinal changes resembling 
white dots in an 11 year old girl with PXE (Figure 23), similar to changes reported previously 
in children with PXE (Aydin et al., 2007). These white dots share phenotypic features similar 
to those observed in retinoid cycling disorders, and might suggest that a thickened BM may 
not fully support transfer of vitamin A at physiological levels. However, this would be 
expected to affect dark adaptation, and a previous study of dark adaptation and scotopic 
perimetry over the peau d’orange area in six PXE subjects found normal thresholds and 
kinetics (Holz et al., 1994).  
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Figure 23. Retinal images from a girl with PXE. A, Colour fundus photograph of the right 
eye aged 11 showing optic disc drusen as well as multiple white-yellow lesions. B, Short 
wavelength AF imaging taken aged 12, showing autofluorescence of disc drusen, but no 
obvious change in AF over the lesions. C, Infrared reflectance image and OCT: there is 
some mottling seen on the infrared reflectance image, but the OCT does not show discrete 
lesions, although BM may be thickened or hyper-reflective. D-F, corresponding images 
from the left eye.  
 
5.2.3 Sjogren-Larsson syndrome (SLS) 
This is a rare autosomal recessive neurocutaneous syndrome characterised by intellectual 
disability, spastic diplegia or tetraplegia and congenital icthyosis. Affected individuals may 
also show retinal involvement, particularly the appearance of bilateral, glistening white dots, 
usually present in the first few years of life. The retinal deposits appear to increase with age 
but have no correlation with the severity of systemic involvement. SLS results from a 
deficiency of fatty aldehyde dehydrogenase (FALDH), an enzyme necessary for the oxidation 
of fatty alcohol to fatty acid (Rogers et al., 1997). Consequently aldehyde modified lipids or 
fatty alcohols accumulate, which are likely to disrupt the function of membranes in the eye, 
brain and skin. The deposits are fine, often hard to photograph, hyperautofluorescent and 
not associated with electrophysiological abnormality (Jagell et al., 1980; Mirshahi and Piri, 
2009).  
 
5.2.4 Kjellin syndrome 
Kjellin described a cohort of patients with spastic paraplegia, mental retardation, 
amyotrophia and central retinal degeneration (Kjellin, 1959). Many years later, the retinal 
phenotype was described further in a family survey (Frisch et al., 2002). Colour photography 
revealed widespread retinal flecks throughout the posterior pole and extending beyond the 
arcades, with a similar appearance to that in ABCA4 retinopathy. CSLO AF imaging revealed 
that the flecks have a central hyperautofluorescent region surrounded by a 
hypoautofluorescent boundary, thus subtly different to the flecks seen with mutation of 
ABCA4. FFA shows absence of a dark choroid, blockage of choroidal fluorescence over the 
lesions with a hyperfluorecent halo in the later stages of angiography. Similar to ABCA4 
retinopathy, electrophysiological changes may not be easily predicted from the anatomical 
changes, as those with widespread flecks may have normal results, or show reduction in full 
field ERG a wave amplitude with increased latency. Despite many similarities, Kjellin 
syndrome is not confused with Stargardt disease as neurological signs and symptoms 
predate the retinal changes (Puech et al., 2011). Recently two genes, ZFYVE26 and SPG11, 
have been identified where bi-allelic mutation results in Kjellin syndrome (Hanein et al., 
2008; Orlen et al., 2009). 
 
5.2.5 Partial Lipodystrophy 
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Lipodystrophies are a large group of disorders involving varying degrees of fat loss. Nolis  has 
recently reviewed the more common genetic and acquired types (Nolis, 2014). Familial 
partial lipodystrophy (FPLD) is a rare disorder involving selective and progressive alteration 
in adipose tissue from various areas of the body. Commonly this involves loss of fat from the 
arms, legs, head and trunk regions but may also include subcutaneous fat accumulation in 
other areas of the body, especially the neck, face and intra-abdominal regions. In most cases 
these changes begin during puberty. Six different subtypes of FPLD have been identified 
each with a different genetic aetiology (FPLD1-6). Four forms of FPLD are inherited as 
autosomal dominant traits; one form (FPLD5) is inherited as an autosomal recessive trait 
(resulting from mutations in the CIDEC gene). The mode of inheritance of FPLD1 is unknown.  
FPLD can be associated with a variety of metabolic abnormalities (glucose intolerance, 
hypertriglycerideaemia) and the extent of adipose tissue loss usually relates to the severity 
of the associated metabolic complications. Systemic lupus erythematosus and 
dermatomyositis may also co-exist as autoimmune conditions.  
FPLD is frequently associated with MPGN2, and often associated with the antibody C3 
nephritic factor (Mathieson et al., 1993). This binds to and stabilises C3 convertase, leading 
to the activation of the alternative complement factor pathway and excessive consumption 
of C3 (Misra et al., 2004; Savage et al., 2009). Increased activity of C3 convertase activity has 
also been proposed as a risk for developing AMD (Helgason et al., 2013; Seddon et al., 2013; 
Zhan et al., 2013). High-risk alleles in CFH similarly act in this pathway. 
Retinal changes similar to those described in MPGN2 and ARMD have been described, even 
in the absence of renal disease. Multiple widespread drusen have been identified which 
later either evolve to atrophy or neovascularization (Jansen et al., 2013; Patel and Page, 
2006; Trabucchi et al., 1998). At least early on, these changes are not associated with 
abnormality in the full field electroretinogram, but a reduced electro-oculogram is noted 
when tested (Trabucchi et al., 1998). 
 
5.2.6 Ring chromosome 17  
Five cases of ring chromosome 17 have been reported with ocular involvement, all with 
features of short stature, mental retardation, epilepsy and café au lait spot in addition to a 
flecked retina appearance (Charles et al., 1991; Gass and Taney, 1994; Kumari et al., 2009; 
Ono et al., 1974; Shashi et al., 2003). Despite these retinal changes, no visual loss has been 
recorded in any of the cases (all under 34 years old). Ring chromosome formation may occur 
by direct telomere-telomere fusion, presumed to be associated with palindromic terminal 
DNA sequences. Alternatively chromosomal material may be lost. The retinopathy may 
result as a non-specific consequence of ring chromosome formation, with a generalized 
effect on cell cycle, or relate to gene dysregulation within the deleted (telomeric) regions. 
Figure 24 shows the retinal appearance of an affected patient, showing multiple yellow 
lesions in the macula that may be drusen or drusenoid deposits. 
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Figure 24. Findings from a patient with ring choromosome 17. A, Karyotyping showing the 
abnormal chromosome. B, Colour fundus photograph from the left eye showing small 
yellow lesions at the macula. Image courtesy of Graeme Black. 
 
5.2.7 Partial Trisomy 10q 
Partial trisomy of the long arm of chromosome 10 is an extremely rare genetic disorder first 
recognised in 1965 (de Grouchy and Canet, 1965). Subsequent reports have highlighted the 
syndromic features of disease, describing severe mental, growth, neurological, cardiac and 
skeletal disease. Facial features include microcephaly, a prominent forehead, low set ears 
and micrognathia, ocular findings predominantly involve the surface and adnexal tissue. 
Retinal abnormalities are less common. The first three reports describing the fundus findings 
did not identify any drusen-like changes (Laurent C, 1973; Prosperi et al., 1977; Yunis and 
Sanchez, 1974), however in two subsequent cases, widespread multiple fine drusen were 
observed (Neely et al., 1988; Tabandeh et al., 2000), and in one case there was associated 
RPE atrophy (Tabandeh et al., 2000). The same year Lam et al described a similar case but 
with widespread RPE abnormalities (Lam et al., 2000).  
The duplicated region almost always includes 10qter, with the most frequent proximal 
breakpoint at 10q24. Variation in the clinical features most likely relates to the exact length 
and location of the duplicated portion of chromosome 10q, and that widespread genetic 
dysregulation contributes to the range of tissues affected rather than a dysfunction in a 
common pathway. Currently, as detailed fundus examinations have not been performed in 
all cases, the genetic link with drusen remains elusive. 
 
6. Conclusions and future directions 
 
The wide spectrum of retinopathies with drusen or drusen-like phenotypes highlight the 
wide range of associated aetiologies. Some patterns however do seem to emerge; soft 
drusen are rarely found outside the macula (except when associated with the CFH mutation 
R1210C); SDD seem to occur in visual cycle disorders and as a consequence of BM thickening 
(PXE, L-ORD, SFD) and spare the fovea. Drusen are likely to represent phenotypic 
convergence for a number of diverse biological processes. Their outcomes, however, vary, 
and it would be valuable to improve our ability to predict the associated long-term effects of 
each druse subtype. Recognising the various forms, and classifying them, is a start. 
As our ability to characterise drusen continues to evolve, further insights into their 
biogenesis are obtained. Future autofluorescent imaging modules will provide quantitative 
as well as qualitative information, both in terms of the amplitude of autofluorescence as 
well as the duration of fluorescence lifetime (Ach et al., 2014). Advances in adaptive optics 
imaging now offer the opportunity to reduce the light backscattered from photoreceptors, 
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revealing the in vivo human RPE mosaic (shown in Figure 25), and the opportunity for 
visualisation of the earliest stages of disease. Another relatively under-investigated structure 
is the choroid, especially as this site is known to show high levels of complement activity 
prior to druse formation. As non-invasive techniques for choroidal imaging (enhanced depth 
imaging, swept source OCT, OCT angiography) are now available and changes within this 
vascular bed may now be routinely visualised and quantified. Along with an improved 
characterisation of fine anatomical details, the importance of functional testing is 
increasingly being appreciated. Psychophysical tests and dynamic electrophysiology offer 
assessment of the kinetics of the visual cycle in vivo, and detailed microperimetry, including 
scotopic and adaptive optics based techniques, adds spatial information to this (Tuten et al., 
2012). Together, these approaches will provide outcome measures for future clinical 
treatments.  
The disorders associated with drusen may seem diverse but two mechanistic themes seem 
to recur – dysregulation of the complement cascade and disruption in the visual cycle. 
Consequently, there has been considerable interest in identifying ways to modify these 
pathways. Lampalizumab is a monoclonal antibody fragment designed to inhibit human 
complement factor D, a rate-limiting enzyme in the alternative pathway. Other targets 
include modulating activity of the plasma protein C3, important in activation, amplification 
and effector generation in the complement response. In parallel strategies, groups are 
targeting bisretinoid production by attempting to modify the visual cycle. Emixustat 
hydrochloride (ACU-4429), specifically designed to inhibit the visual cycle isomerase (RPE65) 
is the first in this category to be tested in a phase II clinical trial (Dugel et al., 2015). Other 
visual cycle modulators are expected to follow, as well as attempts to prevent bisretinoid 
production without affecting the visual cycle. 
We may also need to rethink our strategy for discovering the mechanisms underlying 
conventional druse formation. Genome wide association studies have provided much 
needed insight identifying a few common variants with high pathogenicity but most 
associated polymorphisms are of low effect. Performing the same studies recruiting patients 
with onset of drusen in earlier adult life may help identify rare variants of greater effect, 
involved in the same or novel biological pathways. As the cost of nucleotide sequencing 
continues to fall, these studies may be better performed using whole genome sequencing. 
As it is possible that intronic, or regulatory regions of DNA may be involved, candidate genes 
or regulatory sequences will need further functional analysis. This is now possible, using 
patient-specific RPE cells, generated using an induced pluripotency stem cell model. These 
cells can be aged in a controlled manner, with genetic, epigenetic and environmental factors 
investigated for the effects on cellular phenotypes. With time, rather than culturing 
monolayers of single cells, three-dimensional structures, comprising the RPE and 
neurosensory retina will become possible, providing a more accurate reproducing in vivo 
physiology.  
Although our understanding of drusen has changed relatively little since their recognition 
over 150 years ago, the future now holds significant promise. Neovascular AMD is now 
considered a treatable disease, and our expectations are shifting towards managing the 
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earliest stages, with more attention now focussed on drusen. Strategies to prevent drusen 
formation could be one goal. However, as drusen could also be considered a marker for 
underlying pathogenic processes, prevention of drusen in themselves may not be sufficient. 
Diffuse, rather than focal, thickening of Bruch’s membrane may be more important, and 
strategies aimed at improving transport across this structure may be beneficial. This might 
include upregulation of those matrix metalloproteinases (MMP) shown, over a decade ago, 
to improve hydraulic conductivity, such as MMP-9 (Ahir et al., 2002).  
As more is understood regarding the molecular events, and their genetic and environmental 
modifiers, optimal strategies of disease prevention may emerge. Detailed clinical 
investigations, providing insight into in vivo biology may now be complemented by in vitro 
disease modelling, providing powerful tools to help solve currently unanswered questions. 
 
Figure 25. Adaptive optics scanning laser ophthalmoscope imaging of the human RPE 
mosaic in vivo. 
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Figure Legends 
Figure 1. Development of subclinical deposits and soft drusen. In this cartoon the healthy 
configuration is shown on the left. With ageing (middle diagram), basal laminar deposits 
accumulate (internal to the RPE basement membrane) and vacuoles appear within RPE 
cells; early basal linear deposits (external to the RPE basement membrane) may also 
develop. The right-hand side shows more extensive BlinD coalescing to form soft drusen. 
(PR OS, photoreceptor outer segment; RPE, retinal pigment epithelium; BL, basal lamina; 
CL, collagenous layer; EL, elastic layer;  CC, choriocapillaris; BlamD, basal laminar deposit; 
BlinD, basal linear deposit). 
Figure 2. Retinal imaging from the left eye of an 84-year old man with AMD. A, colour 
photograph shows multiple drusen of varying size (small, medium and large) as well as 
pigmentary change. B, Short-wavelength AF image shows variable hyper- and hypo-
autofluorescence. C, Horizontal OCT scan with corresponding infrared reflectance image 
showing OCT appearance of large and small drusen.  
Figure 3. Images from the right eye of a 47 year-old man with cuticular drusen. A, Colour 
fundus photograph showing drusen and pigmentary change. B, Fundus fluorescein 
angiogram (at 27 seconds after dye injection) showing the characteristic “starry sky” 
appearance. C, Short-wavelength AF showing a mixture of hypo and hyper-
autofluorescence. D, Horizontal enhanced depth OCT scan with corresponding infrared 
reflectance image. 
Figure 4. Appearance of reticular pseudodrusen (RPD) on OCT and infrared reflectance. A, 
Infrared reflectance and horizontal OCT scan through the fovea of an 81 year-old subject 
with a healthy macula. B, Corresponding images from an 87 year-old patient with both 
conventional sub-RPE drusen and RPD (clearly visible on the infrared reflectance image). C 
and D, images from the superior macula in both subjects. “Light stripes” in the choroid are 
also evident in the patient with RPD. 
Figure 5. Hyperreflective pyramidal structures (“ghost drusen”). A, Short wavelength AF 
image from the right eye of a 68 year-old male patient with genetically confirmed late-
onset retinal degeneration (L-ORD), showing marked RPE loss at the posterior pole. B, 
Infrared reflectance (left) and corresponding horizontal OCT line scan (right) through an 
area of geographic atrophy. C and D, Corresponding images from a patient with Sorsby 
Fundus Dystrophy (SFD). Hyperreflective pyramidal structures are visible on the OCT 
images. 
Figure 6. Schematic representation of the retinoid cycle. Asterisks indicate particular 
proteins in which mutations in the coding genes can give rise to white dots. ABCA4 is 
shown here facilitating removal of all-trans-retinal from the outer segment disc lumen.  
Figure 7. Fundus appearance of a patient with genetically proven biallelic mutations in 
ABCA4 (Stargardt macular dystrophy), aged 16 (left images), 21 (middle images) and 25 
years (right images). A-C, colour fundus photographs, with the macular region magnified in 
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the middle panels (Amel et al.), and corresponding short wavelength autofluorescence 
images in the lower panels (G-I). The characteristic hyperautofluorescent flecks are 
evident in the later images, but white dots are also apparent, particularly in the earliest 
image. 
Figure 8. Retinal imaging in a 6 year old patient (A-F) and a 75 year old patient (G,H) with 
Bothnia Dystrophy. A-D, colour fundus images from the younger patient (A and B show 
widefield images; C and D show the posterior pole). E, Infrared reflectance image of right 
macula with OCT scan through the fovea. F, OCT and infrared reflectance image for the left 
eye. The OCT shows what appear to be subretinal drusenoid deposits. G,H, Wide-field 
fundus images from the older patient showing widespread chorioretinal atrophy.  
Figure 9. Images from a patient with fundus albipunctatus (RDH5-associated retinopathy). 
A and B, colour fundus images from right eye aged 7 (A) and 10 (B) years. The later image 
shows a few additional deposits. C and D, Infrared reflectance and OCT images from the 
right eye (aged 10): the deposits appear to be subretinal, but with some discontinuity in 
the ellipsoid layer seen also. E, Short wavelength autofluorescence image from the right 
eye (aged 11): a low overall autofluorescence is seen, but the deposits have higher levels 
of autofluorescence than the background and are visible when the gain is increased. 
Figure 10. Retinal images of a 39 year-old female with bi-allelic mutation in PLA2G5. A,B,C 
Images from the right eye. D,E,F, Images from left eye. A and D are colour fundus 
photographs showing numerous white dots. B and E are short wavelength AF images 
showing that the lesions are hyperautofluorescent. C and F show infrared reflectance and 
OCT images. 
Figure 11. Examples of phenotypes seen in EFEMP1 disease (“dominant drusen”). The 
panels show (from left to right) colour fundus photographs, short wavelength 
autofluorescence, infrared reflectance and horizontal OCT scans, all from the right eye. 
Upper panels (A-C) are from a 21 year old patient with early disease. The middle and lower 
panels are from a sister and brother showing how expression can be variable in the same 
family. The middle panels (Amel et al.) are from a 62 year old female with severe disease. 
The lower panels (G-I) are from her brother (aged 59) who has mild disease. The 
commonly described appearance of radially distributed drusen is not evident in these 
cases, but drusen abutting the optic nerve head are visible (middle and lower panels). 
Figure 12. Retinal imaging from two patients with early or mild SFD. A, Colour fundus 
photograph from the right eye of a 41 year-old female patient. B, Colour fundus 
photograph from the right eye of a 49 year-old female patient. C and D, “Multicolor” and 
short-wavelength AF imaging with CSLO of the patient in A. E and F, corresponding images 
from patient in B. G and H, Infrared reflectance and OCT imaging from both patients. The 
lesions are more possibly more easily defined on the CSLO images (Gauter-Fleckenstein et 
al.) than on the colour fundus photographs (A,B), and OCT imaging shows the majority to 
be SDD. An SFD patient with more advanced disease is shown in Figure 5. 
Figure 13. Images from a 60 year-old female with late-onset retinal degeneration. A, 
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colour fundus photograph from the right eye. B, Infrared reflectance and horizontal foveal 
OCT scan. C, Short wavelength autofluorescence imaging. D, Slit lamp photograph of 
anterior segment showing anteriorly placed zonular insertions, which are seen in this 
condition. Images from a patient with more advanced disease are shown in Fig. 5. 
Figure 14. Fundus images from patients with IMPG2 mutations. A, Wide-field colour 
fundus photograph of the right eye of a 19 year-old male with retinitis pigmentosa found 
to have bi-allelic mutations in IMPG2. B-D, images from the right eye of the patient’s 
mother (aged 39). B, Colour fundus photograph showing subtle drusen-like lesions around 
the fovea and superotemporally. C, Short-wavelength autofluorescence image showing 
hyper-autofluorescence of the lesions. D, Infrared reflectance image with horizontal foveal 
OCT scan. 
Figure 15. Images from the right eye of a patient with bi-allelic mutations in CDHR1. A, 
Colour fundus photograph shows a bulls-eye maculopathy appearance, with fine yellow 
dots at the periphery of the lesion. B, Short wavelength autofluorescence shows speckled 
hyperautofluorescent foci throughout the lesion. C, Infrared reflectance with a horizontal 
OCT scan showing, in addition to outer retinal/RPE atrophy, fine hyperreflective foci at the 
level of the photoreceptor outer segments. 
Figure 16. Images from a mother and son affected by North Carolina Macular Dystrophy. 
Upper panels show colour fundus photographs; lower panels show short wavelength AF 
images. A,C, Images from 16 year-old male with grade 1 NCMD. B,D, Images from 42 year-
old female with grade 3 disease. 
Figure 17. Images from patients with albinotic spots. A-C, 9 year-old girl; D-F, 25 year-old 
female; G,H, 11 year-old male). Images are colour fundus photographs (A,D,E), short 
wavelength autofluorescence (B,D,G) and infrared reflectance with horizontal OCT scans 
(C,F).  
Figure 18. Retinal imaging of a 19 year-old female with large colloid drusen. A and B, 
Colour fundus photographs from right and left eye respectively. C and D, Short wavelength 
AF images. E and F, Infrared reflectance and horizontal OCT scans from right and left eye 
respectively. 
Fig 19. Retinal images from a 41 year-old female with bilateral drusen. This patient 
underwent testing for mutations in the known genes underlying retinal or macular 
dystrophies with a negative result. The symmetry suggests a genetic aetiology. A, Colour 
fundus photographs (from a wide-field imaging system). B, Horizontal enhanced depth 
OCT image through the fovea of the right eye with corresponding infrared reflectance 
image. C, Short wavelength AF images. D, OCT and infrared images from the left eye.  
Figure 20. Retinal images from a 21 year-old female with histologically confirmed MPGN 
type 2. A, Colour fundus photographs. B, Horizontal OCT image through the fovea of the 
right eye with corresponding infrared reflectance image. C, Short wavelength AF images. 
D, OCT and infrared images from the left eye. The drusen-like lesions are visible on colour, 
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AF and infrared imaging, but not easily discernible on OCT. 
Figure 21. Retinal imaging from patients with X-linked Alport syndrome (A-C) and 
autosomal recessive Alport syndrome (Amel et al.). A, Horizontal OCT line scan through 
the fovea of a male patient with X-linked Alport syndrome, showing inner retinal thinning 
largely temporal to the foveola and hyper-reflectivity of the ILM. B, Colour fundus 
photograph from the left eye showing the dot/fleck maculopathy and the macular 
“lozenge” appearance. C, OCT from the left eye (corresponding to the green arrow in B) 
showing that the white yellow lesions appear to correspond to the hyper-reflective ILM 
rather than any drusenoid deposits. D, Montage of colour fundus photographs from a 
male patient with autosomal recessive Alport syndrome showing minimal macular dots, 
but mid-peripheral changes that could be drusenoid. E, F, infrared reflectance and OCT 
images from the right and left eye of the patient depicted in D. Temporal macular thinning 
is again seen together with a hyper-reflective ILM. 
Figure 22. Retinal imaging from a patient with vitamin A deficiency due to liver disease. A, 
Colour fundus photograph showing white dots. B, “Multicolour” CSLO imaging showing 
small discrete deposits. C, Short-wavelength AF imaging showing hypo-autofluorescent 
spots. D, Infrared reflectance imaging and OCT scan showing that the lesions are 
consistent with subretinal drusenoid deposits. E-F, Corresponding images from the left eye 
of the same patient. 
Figure 23. Retinal images from a girl with PXE. A, Colour fundus photograph of the right 
eye aged 11 showing optic disc drusen as well as multiple white-yellow lesions. B, Short 
wavelength AF imaging taken aged 12, showing autofluorescence of disc drusen, but no 
obvious change in AF over the lesions. C, Infrared reflectance image and OCT: there is 
some mottling seen on the infrared reflectance image, but the OCT does not show discrete 
lesions, although BM may be thickened or hyper-reflective. D-F, corresponding images 
from the left eye.  
Figure 24. Findings from a patient with ring choromosome 17. A, Karyotyping showing the 
abnormal chromosome. B, Colour fundus photograph from the left eye showing small 
yellow lesions at the macula.  
Figure 25. Adaptive optics scanning laser ophthalmoscope imaging of the human RPE 
mosaic in vivo. 
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Highlights 
• Besides age-related macular degeneration, drusen and drusen-like deposits can occur in 
normal ageing, and in young age groups; they can also be associated with inherited 
conditions and with systemic disorders. Multimodal imaging can afford a degree of 
differentiation. 
• White dots, drusen or subretinal drusenoid deposits may be seen in a number of inherited 
eye disorders, including visual cycle disorders as well as mutations in the following genes: 
EFEMP1, PLA2G5, TIMP3, C1QTNF5, IMPG1, IMPG2, PRPH2, CDHR1. 
• Common themes emerging include complement dysregulation and alterations in the 
transport of retinoid (either by visual cycle disruption or Bruch membrane thickening), 
yielding insight into pathogenetic mechanisms as well as potential therapeutic targets. 
 
 
